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ABSTRACT PAGE
W e report formation of 2-pyridones from 2,5-diketopiperazines by first accessing
a [2.2.2]-diazabicyclic structure formed from a domino sequence involving aldol
condensation, alkene isomerization, and hetero-Diels-Alder cycloaddition.
Conditions to produce the cycloreversion were optimized to reveal the desired
pyridone functionality. The reaction pathway has been investigated with different
diketopiperazines, aldehydes, and alkynal components, involving both inter and
intramolecular cycloaddition templates. These efforts were directed toward the
synthesis of louisianin B completed in 10 steps with 1.5% yield.
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Chapter 1
Synthetic Approaches Towards Constructing 2-Pyridones
Introduction
2-Pyrid6nes are a common structural moiety found in several biologically active
molecules. Recently, an increased interest in this class of compounds has emerged due to
their wide array of properties, ranging from pharmacological to agrochemical activities.1
2-pyridones are 6-membered heterocyclic aromatic alkaloid motifs; however, other
pyridone isomers exist, such as 4-pyridones. Below in Figure 1.1 is a common
numbering system for pyridone scaffolds, along with the pyridone and hydroxypyridine
tautomers.

2°
3 fi^NH ^

OH
rf^N

5
2-Pyridones

4-Pyridones

Figure 1.1 Structure and tautomeric forms of 2-pyridones and 4-pyridones

The stability of the 2-pyridone compared to the 2-hydroxypyridine has been
debated for many years. It was found that only in very dilute nonpolar solvents or in the
gas phase is the hydroxypyridine be favored. In more concentrated solutions, the
pyridone form is stabilized by forming a dimer through hydrogen bonding interactions. In
aqueous solutions, 2-pyridone tautomers are found to be 1000:1 times more stable than
1

their hydroxypyridine counterparts.2
3-hydroxypyridines, a common scaffold of some bioactive molecules such as
vitamin B6, can exhibit zwitterionic properties through a proton transfer from the
hydroxyl group to the nitrogen in the ring system. They possess a dominant phenolic
character that is caused by their inability to form the energetically favorable keto
tautomers that are present in 2- and 4-pyridones.3
Possessing a wide variety of pharmacological and agrochemical properties,
pyridones and their analogues have exhibited characteristics of DNA gyrase inhibitors,
reverse transcriptase inhibitors for HIV-1, and mycotoxins. In 1864, the first pyridone
alkaloid to be isolated was ricine, a poisonous crystalline substance found in castor beans.
The structure was unknown at the time and not elucidated until 1904 by Maquenne and
Philippe.4 Camptothecin, a 2-pyridone isolated in 1966 from the tree Camptotheca
acuminata in China, was found to be a topoisomerase inhibitor, a characteristic of several
anticancer drugs. Because of its biological activity, camptothecin has become a common
synthetic target. However, in the 1980’s, camptothecin failed clinical trials due to
insolubility in the human body and toxicity. Derivatives of camptothecin have been
approved by the FDA for the treatment of patients with ovarian, small-cell lung, and
colorectal cancers.5 Huperzine A has recently been studied as a molecule of interest due
to its potent reversible inhibition of acetylcolinesterase. For this reason, huperzine A has
been viewed as a possible treatment of Alzheimer’s disease to improve the cognitive
function.1 Aristopyridinone A was isolated in 2011 from Aristolochia, a traditional
Chinese medicinal plant that possesses antibacterial, anti-inflammatory, and anti
2

asthmatic properties.6 Most recently in 2013, four new 4-hydroxy-2-pyridones were
isolated by Koyama from a fungus, Stagonosporopsis cucurbitacearum. One of the
pyridones, didymellamide A, was shown to exhibit antifungal character against azoleresistant C. albicans? The structures of these natural products are shown in Figure 1.2
below.

OMe

^ iA

o

Me
Ricine
Isolated: 1864
Total Synthesis: 1923

Me

OH O

(+)-Camptothecin
Isolated: 1966

Huperzine A
Isolated: 1994

Didymellamide A
Isolated: 2013

(+)-Aristopyridinone A
Isolated: 2011

Figure 1.2 Isolated alkaloid natural products possessing a pyridone moiety

Synthetic Methods Toward Pyridones
2-Pyridones have been accessed using two main strategies: functionalizing a
pyridine core or constructing the heterocyclic ring through various types of reactions,
including

condensations,

organometallics

catalyzed

[2+2+2]

cyclizations,

and

cycloadditions. Oxidation of pyridines has been shown in several examples to be a facile
route toward the formation of 2-pyridones (eq 1) (Scheme 1.1). Potassium ferricyanide
can oxidize pyridines with high yields. Pyridones have also been constructed
3

through the hydrolysis of a-halopyridines, (eq 2) (Scheme 1.1).1
M e s y ^ . M e 1) Me2S04, 110 C

(1)

2) NaOH, K3Fe(CN)6

N

Me

Ar\ ^ ^ A r

1,4 Dioxane/HgO^Ai v ^ ^ Ar________________________(2)

I ST^F

ISf^O H

h

°
92%

Scheme 1.1 Oxidative methods for the synthesis of 2-pyridones
Since condensations are believed to be the mechanism through which 2-pyridone
derivatives, such as 4-hydroxy-2-pyridones, are constructed biologically, many groups
have utilized this type of reaction to form the desired pyridone core structure. Pyrones
have been converted into pyridones using a condensation reaction.8 Pyrone 1 was treated
with ammonia, causing addition into the carbonyl, opening to intermediate 2 (Scheme
1.2). The nitrogen of the newly formed amide could then attack the aldehyde, closing the
ring system to form the desired pyridone 3.
NH3

O

O

NH3, dioxane

l 2075y 2h

>

( f j j NH

1

3

A

c
?vn+h3
C ?

1

i ^ n nhh ,2
[f

Scheme 1.2 Conversion of pyrone to pyridone
4

_

X

hfi cr

]2

In 2000, Camps synthesized the acetylcolinesterase inhibitor huperzine A through
a condensation reaction (Scheme 1.3).9 The [3.3.1] bicycle of the natural product was
initially constructed, which required the pyridone moiety to be subsequently appended.
The condensation of pyrrolidine with the ketone of bicyclic structure 4 afforded an
enamine that could undergo a conjugate addition with propiolamide. Hydrolysis of the
pyrrolidine reveals the ketone, allowing for condensation with the pendant amide,
cyclizing and forming the desired 2-pyridone. While the conjugate addition was not
appreciably regioselective, the 2-pyridone of huperzine A was synthesized by Camps
with 40% yield, and the regioisomer, 5, was produced with 26% yield.

Me

Me
26%
NH

Me
,0

NH

NHCOoMe

1) pyrrolidine,
benzene 80 °C

NH
Me

Me

NHCOoMe
NH.

40%

NHR

NH

Huperzine A

Scheme 1.3 Pyridone formation in Camps synthesis of huperzine A

Organometallic reagents have been heavily used to synthesize 2-pyridones, a
summary of/ which is shown in Table 1.1. Yamazaki, in 1977, utilized methyl
phenylpropiolate and methyl isocyanate along with a cobalt catalyst in their efforts to
facilitate [2+2+2] cycloadditions, a general scheme of which is shown in Figure 1.3.10
5

u *c
in" NR [2+2+2] >

Figure 1.3 General [2+2+2] cycloaddition

In 1982, Hoberg used a nickel catalyst with both symmetric and asymmetric alkynes and
isocyanates to form pyridones in a partially regioselective manner. Vollhardt, in 1984,
utilized a cobalt catalyst to enable a pseudo intermolecular cycloaddition between a
tethered alkyne and isocyanate pair and a second alkyne.11 The purpose of tethering was
to limit regioisomers that would be formed through the cyclization reactions that had
been noted with previous organometallic reactions. Itoh, in 2005, looked to use the first
ruthenium catalysts for pyridone synthesis, using a similar tethering approach with 1,6diynes and isocyanates.

1^

In 2009, Rovis was able to access both 2-pyridones and 4-

pyridones using a rhodium catalyst in a regioselective intermolecular [2+2+2]
o

cycloaddition. More recently, Takeuchi, in 2012, looked to use iridium as a catalyst
when tethering two alkynes together and varying the substituents on the isocyanate.

1^

Kondo, in 2006, expanded on previous rhodium catalysis to achieve selectivity between
the formation of pyridones and pyrimidines using isocyanates and symmetric alkynes.14
The proposed catalytic cycles for these transformations are shown in Figure 1.4.

6

Author, Year

Metal Catalyst

Starting Material

Pyridone Scaffold
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Table 1.1 Summary of organometallic catalysts for pyridone synthesis

7

R i = p-MeO-C6H4
= Bn, PMB, Ph,

R 2

X t 2rXXr

r 2n = c= o

n-hex, cyclohexyl,

^

Et

R i ^ r A i

Takeuchi,
2012

R=Bn
cyclohexane,
NR
furan, Ph
R = Ph, P-tolyl,

|

Et

Rovis,
2009

-O
-NTs

R = Bn, Ph, Cyclohexane, Furan

O
Kondo,
2006

R = TMS, Me, f-Bu
R, = TMS, Et, C 0 2Et

Ri—E=— R1

R2- N = c = 0

Figure 1.4 Proposed catalytic cycle for metal-catalyzed [2+2+2] cycloadditions

In 2002, Takahashi’s work led to a highly regioselective 2-pyridone synthesis
using stoichiometric amounts of both zirconium and nickel.15 Zirconium initially forms
metallocycle 6 after reaction with an alkyne and isocyanate (Scheme 1.4). This is
followed by transmetallation to form the nickel metallocycle 7, after which regioselective
insertion of a second alkyne occurs. Takahashi was able to produce a single regioisomer
8 with relatively high yields for each reaction by selective addition of the alkynes and
isocyanates.

8

CpoZrEto — ~ ~ — — 4
K2
2
-78 to 0 °C

6

v

Ph

Rc
R1
Ph
Ph
Me

R2
Ph
Ph
Ph

R3
Ph
Me
Ph

R4
Ph
Ph
Ph

Re
50 C
Ph

O

N

R4

Ph

8

Scheme 1.4 Takahashi’s proposed mechanism for cyclometallation and pyridone
formation

Other organometallic reactions have been utilized to form 2-pyridones, including
the palladium-catalyzed Stille reaction and the zinc-catalyzed Blaise tandem reaction.16,17
Choice of both metal and ligand can greatly impact the ability of transition metal
mediated cyclization to form these alkaloid structures, and for this reason, many authors
screen various metal and ligand combinations. Several of the abovementioned catalysts
were incompatible with terminal alkynes; however, Tanaka, in 2005, reported the use of
terminal alkynes to synthesize various pyridones with chiral rhodium catalysts.

1o

These

are some of the examples of reactions that have been utilized to achieve the construction
of 2-pyridone skeletons.

9

Cycloadditions and Cycloreversions to Produce 2-Pyridones
Cycloadditions and cycloreversions have been used to construct several types of
aromatic systems, includmg pyrimidines,

1A

pyridines,

AA

and pyridones.

A1

Cycloadditions

are characterized by the interactions of two n systems from the diene and the dienophile.
Thermal conditions allow the pericyclic donation of electrons from HOMO of the diene
into the LUMO of the dienophile (Figure 1.5).

HOMO

LUMO

HOMO

SH
Constructive
Orbital Overlap

LUMO
Destructive
Orbital Overlap

HOMO-LUMO Interactions
f°r an Endo Diels Alder

Figure 1.5 Orbital representation of a [4+2] cycloaddition

Diels-Alder cyclizations, [ 4t z + 2n] cycloadditions, conventionally occur with an
electron rich diene and electron poor dienophile. Manipulations of the diene and
dienophile by the addition of electron donating and electron withdrawing substituents,
respectively, can help facilitate cycloadditions. Constructive overlap of the involved n
orbitals is required for the cycloaddition to proceed. Cycloreversions, or retro-DielsAlder reactions, are the reverse of cycloadditions, generating two separate n systems.
Cycloadditions of heterocyclic systems with a dienophile form bicyclic
intermediates, which are often able to undergo a cycloreversion. In many of these cases,
however, the bicyclic intermediate is not thermally stable and cannot be isolated due to
the temperatures required to drive the

cycloaddition. For a cycloreversion of a
10

bicyclic cycloadduct to occur, one bridge must be lost, although there are several
possibilities for the specific byproduct formed. 22 Diatomic nitrogen, carbon dioxide, 1
hydrogen cyanide,20 and acetonitrile are some of the compounds that are commonly used
as the cleaved bridge for the cycloreversion. Some examples of dienes and the
corresponding leaving bridge include oxazoles, where water is subsequently lost as a
byproduct of the cycloreversion, and monotriazines, in which diatomic nitrogen is
expelled.23 Oxazinones, for example, have been used because when the cycloreversion
occurs, carbon dioxide is produced. Cycloadditions of oxazinones followed by
cycloreversions have often been used to form pyridines; however Shioiri was able to
form pyridones such as 9 using oxazinones (Scheme 1.5).24

X
COoMe
TMSO

1 )-C 0 2
2) H20
-TMSOH

TMSO

1 8 0 -1 9 5 °C
COpMe

J \ X 0 2Me
CT^N
H

R

R = Ph, Bn, p-N 02C6H4,
X = X, C 0 2Me

Scheme 1.5 Use of oxazinone to form 2-pyridones

In 1972, Sammes worked on using pyrazines to* form pyridones through a DielsAlder cycloaddition followed by cycloreversion (Scheme 1.6).

Using pyrazme 10,

heating to 100 °C for 30 minutes provided direct formation of two regioisomeric 2pyridones, 11 and 12, through loss of isocyanic acid. Symmetric pyrazine 13 was used to
show that loss of isocyanic acid from cleavage of either bridge would produce the same
pyridone, 14, and not result in a mix of regioisomers.
11

Scheme 1.6 Utilization of pyrazines to form pyridones
N-Alkyl pyrazinones were also investigated to exemplify the breadth of substrates
that could be accessed (Scheme 1.7). However, with a protected nitrogen species, such as
lactim o-ethyl ether 15, the desired cycloreversion product 16 was not observed, even
when the cycloadduct was heated to 200 °C. The authors instead used hydrochloric acid
hydrolysis of the dimethyl acetylenedicarboxylate (DMAD) cycloadduct to access
triester-substituted pyridones.
CQ2Me

EtO

N

Me DMAD r.

Me

16
Me

O

HCI

15

Scheme 1.7 Conversion of blocked pyrazinones to pyridones

Sammes, in 1978, furthered his

previous

work

to

construct

dihydropyridones, which could then be oxidized to the desired pyridone structures
(Scheme 1.8).26 The intramolecular cycloaddition between a dihydroxypyrimidine core
and a pentene side chain of 17 required a temperature of 198 °C for 6 hours in DMF to
produce the desired bicycle 18. The cycloreversion then occurred through cleavage of
either lactam bridge, resulting in the loss of isocyanic acid once heated to 200 °C for a
prolonged number of hours, forming the desired dihydropyridone 19. Direct access of the
dihydropyridone was possible in one step if the starting pyrimidine was heated to 200 °C
for an extended period of time.

200 °C

198 °C, 6 h

HN“^ N

DMF

Me

O

H

18

Xylenes

Scheme 1.8 Formation of pyridones from dihydropyrimidines

The use of the alkene side chains required a later oxidation by heating in xylenes over a
palladium-carbon catalyst to access the desired pyridone core 20. To assess the
applicability of the reaction, Sammes looked at using a hexene side chain to act as the
dienophile. Extended reaction times were required for the longer chain length substituent.
Sammes extended his work by synthesizing actinidine, 21, using an intramolecular
cycloaddition,21 but this time using an alkyne side chain. This set up for subsequent
13

cycloreversion to form the aromatic system through loss of isocyanic acid (Scheme 1.9).
Direct access of the 2-pyridone was achieved by using an alkyne; however, Sammes
desired a pyridine in the final product.

Me

Me

Me

Me

198 °C

HO.
NH

DMF

Me

HN

Me

Me

actinidine 21

Scheme 1.9 Sammes synthesis of actinidine

Formation of pyridones through cycloadditions does not always require a
cycloreversion as had been utilized in the above examples. In 1981, Ghosez utilized a
Diels-Alder cycloaddition to form 2-pyridones.27 Acetylacetamide and formylacetamide
were converted into the necessary imides by using tert-butyldimethylsilyl triflate to form
silylated ether azadiene, 22. These could then be allowed to react with DMAD refluxing
in chloroform to form the desired pyridone 23 after hydrolysis with HC1 (Scheme 1.10).
Formylacetamide was combined with methyl propiolate to form pyridone 24
regioselectively once refluxed in benzene for 14 hours followed by hydrolysis.

14

TBSO
Y *

DMAD

T B S 0 ^ /v Ns^ C 0 2Me

NvJ - R

|_jq|

"X^OCfeM
e
X
COgMe

OTBS

HNt*S

“

'CC)2Me

TBSO R

R
23

22
R = H, Me
TBSO
Y ^

'>H‘

NY H

=— C 0 2Me

ii)~HCI

° Y ^ ]

**

C 0 2Me

OTBS

24

Scheme 1.10 Accessibility of pyridones using a Diels-Alder cycloaddition

Pyridines have also been synthesized using a cycloaddition followed by a
cycloreversion. Sammes showed that this could be achieved using pyrimidine 25 and a
pentene side chain that could undergo a cycloaddition. Heating the pyrimidine at 198 °C
for 18 hours led to direct access of pyridine 27 (Scheme 1.11). The intermediate bicycle
26 was isolated when heated to 145 °C.

198 °C

Me

O

DMF

-HNCO
Me‘

26

Me
27

Scheme 1.11 Construction of pyridines from dimethylpyrimidines

Loss of either isocyanic acid or acetonitrile was possible with the bicyclic intermediate;
however, Sammes observed only loss of isocyanic acid. Even with these two competitive
cycloreversions, the cleavage of isocyanic acid was seen to be most favorable. Following
the cycloreversion, aerial dehydrogenation

produced the desired aromaticity, not
15

requiring the authors to perform a subsequent oxidation step.
In 1989, van der Plas looked at steric and electronic effects for inverse electron
demand Diels-Alder reactions.

It was proposed that steric hindrance more greatly

impacted the reaction rate than did electronic effects. Furthermore, the authors examined
six different substrates and suggested that cycloadducts were formed as intermediates;
however, they were not isolated. Instead, they were thought to undergo spontaneous
cycloreversion to form pyridines when heated to 180 °C, a similar finding to Sammes’
work from 1977. Several other cases reported that the intermediate cycloadduct could
not be isolated, and instead, a cycloaddition followed by cycloreversion occurred in one
process. In this work, van der Plas focused on substituent effects on the cycloaddition but
also demonstrated that even though the substituents were varied, the cycloreversions in
all six cases occurred spontaneously following the cycloaddition (Scheme 1.12).

NC

NCNC

CN
R = H, Br, Cl, Me, OMe, NO;

NC CN

Scheme 1.12 Cycloaddition and spontaneous cycloreversion to form pyridines
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Constructing 2-pyridones through cycloadditions and cycloreversions has been
studied for many years. Many of these reactions require high temperatures and several
hours to form desired pyridones through a bicyclic intermediate. Heating some of the
compounds proved to be futile, since even temperatures up to 200 °C could not produce
decomposition of the bicycle into the desired pyridone. However, many authors noted
that the intermediate bicycle could not be isolated and, instead, at high temperatures
directly accessed the 2 -pyridones.
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Chapter 2
Methodological Approaches Toward 2-Pyridones
Previous Cycloreversions to Produce 2-Pyridones
Sammes, in 1973, demonstrated how a 2,5-dihydroxypyrazine diene, such as 1,
could undergo a cycloaddition with a dienophile, dimethyl acetylenedicarboxylate
(DMAD) (Scheme 2.1).1 When heated to 100 °C for 30 minutes, both the cycloaddition
and cycloreversion occurred, forming a 1:1 mixture of regioisomers, pyridones 3 and 4.
The bicyclic intermediate 2 was not isolated. Cycloadditions with A-alkyl pyrazinones
were also explored with DMAD as the dienophile. Cycloadduct 5 formed at room
temperature and was then heated to 200 °C to drive the cycloreversion; however, this was
not a sufficient set of conditions to form the desired pyridone 6 .
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Scheme 2.1 Sammes’ work on cycloreversions to 2-pyridones
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Development of Cycloaddition Conditions Towards [2.2.2]-Diazabicycles
The class of molecules containing a [2.2.2]-diazabicyclic structure has members
including malbrancheamides, brevianamides, and stephacidins and possesses a wide
variety of biological activities. Previous works in the Scheerer lab have demonstrated
how [2.2.2]-diazabicycles can be constructed using a diketopiperazine (DKP) diene in an
intermolecular

Diels-Alder

cycloaddition

(Scheme

2.2).

The

intermolecular

cycloadducts 7 and 8 with the lactim ether bridge proved to be stable in toluene to a
temperature of 110 °C for 16 hours, similarly to Sammes’ work with a lactim ethyl ether
bridged cycloadduct.

However, one intermolecular cycloadduct, 9, underwent 50%

conversion to 2-pyridone 10 once heated in toluene to 110 °C for 24 hours.
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Scheme 2.2 Intermolecular cycloaddition examples from Scheerer lab

We wanted to investigate intramolecular examples to see if the bicyclic structures
were stable to heating like regioisomers 7 and 8 or if they would undergo a
cycloreversion, similarly to cycloadduct 9.

Beginning with a serine-derived DKP with
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a chiral phenyl aminal substituent, a one-pot domino sequence, consisting of an aldol
condensation, alkene isomerization, and intramolecular Diels-Alder cyclization, could be
\

used to access the desired [2.2.2]-bicyclic core (Scheme 2.3).
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Scheme 2.3 Domino reaction sequence to access [2.2.2]-diazabicycles

Two sets of conditions were optimized so that we could study enolizable and nonenolizable aldehydes in the construction of eight different [2 .2 .2 ]-diazabicycles with good
diastereoselectivity;4 a selection of examples is shown in Scheme 2.4. With
nonenolizable aldehydes, it was possible to employ conditions of sodium methoxide in
methanol followed by heating the reaction to 65 °C. However, this cannot be exploited
with enolizable aldehydes due to potential undesired aldol products. To circumvent this,
we envisioned a stepwise one-pot scheme accessing similar intermediates.
First, LiHMDS was used to form the DKP enolate, which is followed by
subsequent

aldol

addition

into

the

aldehyde. The derived metal alkoxide is
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acetylated with acetic anhydride, facilitating elimination. Treatment with DBU both
effects acetyl elimination to 11 and alkene isomerization to the azadiene 12. Upon
heating, the cycloaddition is observed with the pendant alkene or alkyne dienophile.

Nonenolizable Aldehydes (Condition A)

O

H Ph

1
IN O
\

MeO
N

/

68 %
(>95:5)

MeO
Enolizable Aldehydes (Condition B)
H Ph

'A

o

CHO

ijj

40%
(>95:5)

13
Condition A: a) DKP (1 equiv.), ArCHO (2 equiv.) at 0 .1 5 -0 .2 M in
MeOH.NaOMe (3 equiv.), 65 ° C 1 6 - 2 4 h; Condition B: a) DKP
(1 equiv.), LiHMDS (1.1 equiv.), - 7 8 °C; b) RCHO (1.2 equiv.), - 7 8 °C;
c) Ac20 (1.3 equiv.) - 7 8 °C to rt; d) DBU (2 equiv.) rt to 90 °C, 16 h.

Scheme 2.4 Examples of [2.2.2]-diazabicyclic structures

One intramolecular example demonstrated use of an aliphatic alkyne as the reactive
dienophile, as seen in cycloadduct 13 (Scheme 2.4). This cycloadduct was isolable and
the cycloreversion product was not observed by NMR. Our lab had demonstrated that the
[2 .2 .2 ]-diazabicycles we synthesized were generally stable to temperatures around 100
°C; however, one example had shown conversion to a 2-pyridone through a
cycloreversion. For this reason, we looked to see if we could optimize conditions to
undergo a cycloreversion to form 2 -pyridones.
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Diketopiperazine Syntheses
A chiral aminal substituent was necessary for our previous synthesis of the
[2 .2 .2 ]-diazabicyclic structures; however, with our projected route, diastereoselectivity
was not necessary due to the lack of stereochemistry present in the pyridone scaffold.
Two DKPs were used in these efforts, one proline derived, 14, and the other glycine
derived, 15 (Scheme 2.5).

78%,
3 Steps

14
a) Et3N, 0 °C

O

n

OMp
55%,
3 Steps
OMe

OMe
15

OMe

Scheme 2.5 Route towards the proline and glycine derived diketopiperazines

In both routes to the desired DKPs, the amino acid ester starting materials were acylated
with chloroacetyl chloride. An azide displacement was then performed to set up for the
Staudinger reduction of the azide, followed by an aza-Wittig cyclization to afford the
proline and glycine derived DKPs in 78% and 55% yields, respectively.
The dimethoxybenzyl (DMB) protecting group was selected because it could later
be removed to reveal a free secondary amide. Initially, a pivaldehyde-glycine derived
DKP, 16, as well as a Boc protected DKP, 17, had been synthesized for eventual cleavage
25

to reveal the unprotected pyridone (Figure 2.1). The Boc DKP was shown to be unstable
when purified on silica gel, and the pivaldehyde-glycine DKP was not as efficient for the
domino sequence compared with the DMB DKP. The cycloadducts from the
pivaldehyde-glycine DKP were complicated by diastereomers. We envisioned that we
could show the versatility of our methodology if we could utilize both the glycine DKP
as well as the sterically congested proline DKP.

O

tBu

O

O

NDMB

NBoc

OMe
27% yield
over 4 steps

16

OMe
12% yield
over 4 steps

OMe
55% yield
over 3 steps

17

Figure 2.1 Pivaldehyde and Boc protected diketopiperazines

Cycloaddition Conditions and Initial Attempts Towards Cycloreversion
We wanted to build upon the one pot domino sequence to incorporate a
cycloreversion. We began our studies with a commerically available non-enolizable
aldehyde, 2 -ethynylbenzaldehyde, and wanted to see if our previous conditions using
sodium methoxide in methanol could produce the desired cycloadduct. Mostly starting
material was present along with a significantly nonpolar compound. After isolation, the
product was determined to be l-methoxy-3-methylene-l,3-dihydroisobenzofuran, 18,
which is thought to form through addition of the alkoxide base into the carbonyl of the
aldehyde, followed by addition into the unsaturated alkyne to cyclize (Scheme 2.6).
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CHO

NaOMe, MeOH,

18
OMe

OMe

OMe

or
HOMe

Scheme 2.6 Dihydroisobenzofuran formation from sodium methoxide conditions

We had to approach the reaction through the more stepwise pathway using the
enolizable aldehyde conditions determined previously. We also wanted to look at a
substituted alkyne; therefore 2 -(phenylethynyl)benzaldehyde was synthesized and also
used in the one-pot reactions. Using the stepwise conditions provided us with a way to
form the desired cycloadducts. We were able to isolate the bicyclic intermediates and did
not observe cycloreversion to occur in the one pot sequence when heated in toluene to
100 °C overnight. Since the bicycles were isolable, we wanted to see if accessing higher
temperatures could drive the cycloreversion.
Our initial attempts involved the cycloaddition of the pivaldehyde-glycine derived
DKP 16 and ethynylbenzaldehyde. Cycloadduct 19 was heated in toluene in a sealed tube
at 130 °C for 17 hours, which was shown to be too mild, resulting in the isolation of the
bicyclic starting material. The reaction was attempted again with DMF at 150 °C for 24
hours and showed signs of formation of a methoxypyridine 20, an undesired
cycloreversion that cleaved the bridge containing the amide (Scheme 2,7).
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i) LiHMDS

16

19

20

Scheme 2.7 Formation of methoxypyridine

Previous works required significantly higher temperatures than are possible with toluene,
so we looked to utilize microwave technology to determine if we could pass the thermal
threshold to cleave the desired bonds to form 2 -pyridones selectively.

Previous Uses of Microwave Technology
Microwave Assisted Organic Synthesis (MAOS) was first reported to accelerate
reaction rates when studied by Gedye and Giguere in 1986.6 The principle behind
microwave-enhanced chemistry is that solvents or reagents can absorb the microwave
irradiation and convert it to heat through dipolar interactions. As the electric field is
changed, the dipoles of the reagent attempt to align with the field; consequentially,
energy is lost in the form of heat. If there is not sufficient time for the dipoles to realign
or if they align too quickly, no heat will be produced. Solvents are chosen based on
physical properties, and those with small dielectric constants are preferred since they are
microwave invisible (e.g. toluene, DCM, THF). The vessels that are used in microwaves
are also generally microwave “invisible” and are made of borosilicate glass, quartz, or
Teflon.
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Organic reactions are frequently run in oil baths for conductive heating, where the
vessel and the solution closest to the walls of the container are heated the most.
Microwaves access the dipoles of the solvent and reagent to heat the system internally,
known as in-core volumetric heating. Microwave reactions can occur in either open or
sealed systems. High boiling microwave active solvents have been used in open systems;
however, in the 1990s, Strauss began work with sealed systems. This advantage allows
for accessibility of higher temperatures from the pressurized system without requiring
changes in volume. The solvents used can be heated well above their boiling points at
atmospheric pressures. For example, methanol can be heated more than 100 °C above its
boiling point when submitted to microwave conditions in a sealed tube without risk of
explosions.3
Various reactions including transition metal couplings, carbonylations, ROMs,
f\ 7
radical reactions, and rearrangements have been shown to work well in microwaves. ’
Cycloadditions were some of the first reaction types attempted in microwave systems.
Dichlorobenzene and xylenes were solvents that had previously been used in some
reactions to access temperatures to drive cycloadditions and cycloreversions. These high
boiling solvents could prove to be problematic to separate from the product once the
reaction was complete. Microwaves allow lower boiling solvents, such as toluene, to
access temperatures much higher than their boiling points without the complication of
solvent removal. With the controlled temperature and pressurized systems, we hoped to
apply microwave technology to access our cycloreversion products.
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Cycloreversions Using Microwave Technology
Submitting cycloadduct 19 to the microwave in toluene for 1 hour with a
maximum temperature of 248 °C, we were able to cleave the bridge containing the
pivaldehyde-protected

lactam,

producing

methoxypyridine

20,

the

undesired

cycloreversion product (Scheme 2.7). Similar results were seen when heated in DMF to
form the pyridine. This demonstrated that a cycloreversion could occur, but the
electronics of the bridges had to be manipulated to form a 2 -pyridone selectively.
We anticipated that substituting a more electron-withdrawing group in place of
the methyl ether could produce the desired cleavage. Another group such as a more
electron withdrawing substituent could pull electron density away from the bonds
through induction, making the C-N bond weaker and more prone to breaking. Several
groups with more electron-withdrawing character were explored including Boc (21),
triflate (22), and acetate (23) protection on the oxygen as well as sulfonyl (24) protection
on the nitrogen. An electron donating substituent, a thiophenol (25), was also used to
determine whether it could facilitate the cycloreversion. This retrosynthetic scheme is
shown in Scheme 2.8.
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Scheme 2.8 Retrosynthesis using electron withdrawing substituents

The Boc protected cycloadduct 21 required temperatures no higher than 170 °C due to the
thermal instability of the Boc group, leaving the lactam precursor from cleavage of the
Boc group instead of the desired cycloreversion product. This protection did not seem
practical because it requires at least two hours at the lower temperature so as not to cleave
the protecting group preferentially. The acetate, triflate, sulfonyl, and thiophenol
derivatives could withstand temperatures above 170 °C and worked well to facilitate the
desired transformation. In practice, we selected acetate protection because it is a simple
procedure, generally not requiring purification and instead allowing for direct submission
to the microwave.
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Scheme 2.9 Route toward 2-pyridones

Using four examples of intramolecular cycloadducts that were subsequently
acetylated, we have been able to demonstrate the microwave-assisted cycloreversions
could be achieved (Scheme 2.9). Overall, we were able to show that our route can
produce these 2 -pyridones in a range from 31 to 60 percent yields over the course of four
steps (Scheme 2.10).
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a) i) DKP (1 equiv.), LiHMDS (1.1 equiv.), - 7 8 °C; ii)ethynylbenzaldehyde (1.2 equiv.), - 7 8 °C;
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Scheme 2.10 Synthesized [2.2.2]-diazabicycles and corresponding 2-pyridones

Deprotection of DMB Pyridones
After constructing the pyridones, we planned to deprotect the DMB containing
o

products. TFA has been shown to cleave a DMB protecting group, and we utilized this
in conjunction with microwave technology to reveal the final deprotected pyridone, 38,
for the phenyl-substituted example, 34. This was completed in a 78% yield (Scheme
2.11). By establishing conditions for the deprotection, we were able to show the
applicability of this route and the ability to reveal a secondary amide.
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Scheme 2.11 Deprotection of DMB pyridone

Intermolecular Examples
We have been able to demonstrate that aldol condensation, elimination,
isomerization and intramolecular cycloaddition of diketopiperazines followed by
cycloreversion can access 2 -pyridones and wanted to extend our work to see if
intermolecular examples could be produced. Dimethyl acetylenedicarboxylate (DMAD)
was chosen as the dienophile and because of DMAD’s ability to act as a Michael
acceptor,9 azadiene 39 had to be isolated first, followed by the intermolecular
cycloaddition with DMAD.
Using the proline DKP, we were able to isolate the cycloadduct 40, in 37% yield.
With this in hand, we wanted to see if the high temperature microwave conditions could
reveal the desired cycloreversion with these intermolecular examples without requiring
an electron-withdrawing substituent. Reaching a temperature of 253 °C provided
methoxypyridine 41 with the isocyanate substituent that arose from cleavage of the
undesired bridge (Scheme 2.12).
Attempting the same sequence of lactam formation (42) and acetylation followed
by cycloreversion was shown to provide the desired 2-pyridone, 43, in 75% yield from
the cycloadduct, similarly to the intramolecular cases. For this specific example, the 234

pyridone was accessed both in the microwave but also when the acetylation reaction was
heated to 140 °C, showing how the thermal barrier was significantly lowered and could
be achieved by heating with a traditional oil bath. This is the only example we have
encountered where the barrier to the 2 -pyridone was low enough to access using thermal
heating with an oil bath. We have since directed our attention toward accessing
intermolecular Diels-Alder examples using the DMB DKP and examples with other
dienophiles such as phenylacetylene, but have yet to optimize conditions to produce a
desired intermolecular cycloadduct.
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Enolizable Aldehyde Substrates
Intramolecular cases that were previously explored only looked at non-enolizable
aldehydes, ethynyl benzaldehyde derivatives. Two examples of enolizable aldehydes
were used, aldehyde 44 that we planned to use on our route toward louisianin B (Figure
2.2) and TMS protected pentynal 45 (Scheme 2.13). The former example will be
discussed in more detail in Chapter 3 that focuses on the synthesis of louisianin B. The
cycloaddition using the TMS protected aldehyde worked in high yield to form
cycloadduct 46. Similar conditions to form the 2-pyridone were employed and the final
TMS pyridone, 48, was constructed in three steps from the cycloadduct in 77% yield.

Figure 2.2 Enolizable aldehyde used toward louisianin B synthesis
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Scheme 2.13 Enolizable aldehydes used in synthesis of 2-pyridones
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Conclusions
We were able to utilize our one-pot conditions to access several [2.2.2]diazabicyclic cores using two DKPs and various alkynyl aldehydes. Thermal heating in
an oil bath or in a sealed tube could not achieve the desired cycloreversion. Instead, we
had to substitute an electron-withdrawing group, specifically an acetate, in place of a
methyl ether. This allowed for more facile bond cleavage to access the desired 2pyridones. Higher temperatures were also required, and for this reason we used
microwave technology to heat the system well above the boiling point of the solvent,
toluene. Once we accessed temperatures above 250 °C, we observed the desired
cycloreversion to form 2-pyridones with yields ranging from 57 to 83% for the three
steps after the formation of the bicyclic intermediate. Through this methodological work,
we were able to use non-enolizable and enolizable aldehydes in intramolecular
cycloadditions as well as begin to investigate intermolecular examples to form 2 pyridones.
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E x p e r im e n ta l S e c tio n
CHO
h2n

DMBN

C 02Me

A ^ci
C 02Me

OMe

Methyl

o

OMe

2-(2-chloro-./V-(2,4-dimethoxy benzyl)acetamido)acetate.

Following

the

procedure from Muhuhi, Joseck et al.1 to a solution of 2-4-dimethoxybenzaldehyde (0.88
g, 5.34 mmol) dissolved in CH2CI2 (40 mL) was added EtsN (1.10 mL, 7.96 mmol),
glycine methyl ester hydrochloride (1.00 g, 7.96 mmol) and NaB(OAc)3H (2.20 g, 10.7
mmol). The slurry was vigorously stirred for 24 h at rt. The reaction mixture was
quenched with the addition of saturated aqueous NaHCC>3 and the mixture was
transferred to a separatory funnel.

The organic layer was removed and the aqueous

portion was extracted with CH2CI2 (3 x 100 mL). The organic portions were combined,
washed with brine, dried with sodium sulfate, filtered, and concentrated in vacuo to yield
a clear oil (1.30 g, 5.44 mmol, 70% yield). The resulting product was used without
purification. The oil was dissolved in CH2CI2 (15 mL) and cooled to 0 °C. To the
solution was added chloroacetyl chloride (0.45 ml, 5.71 mmol) and Et3N (0.83 ml, 5.98
mmol) dropwise and the reaction mixture was warmed to rt and stirred for 18 h. The
reaction mixture was filtered through celite and the filtrate was washed with NaHC03 (3
x 75 ml). The combined organic layers were dried with sodium sulfate, filtered, and
concentrated in vacuo. The residue was purified by flash column chromatography on
silica gel (elution: 25% to 85% EtOAc in hexanes) to afford the acetylated product (1.40
1 Muhuhi, Joseck; Spaller, Mark R. J. Org Chem. 2006, 71, 5515-5526.
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g, 4.44 mmol, 82% yield) as a light orange oil: TLC (40% EtOAc in hexanes), R/: 0.40
(UV, CAM); IR (film) 3002, 2953, 2839, 2361, 1749, 1662, 1614, 1509, 1457, 1440,
1294, 1267, 1210, 1130, 1033, 939, 835, 792, 709 cm'1; •H NMR (400 MHz, CDC13)
7.25 (d, J= 8.2, 1H), 7.03 (d, J= 8.5, 1H), 6.46 (s, 1H), 6.44-6.41 (m, 1H), 4.58 (s, 1H),
4.52 (s, 2H), 4.35 (s, 2H), 4.11 (s, 2H), 4.03 (s, 1H), 4.02 (s, 2H), 3.80 (s, 3H), 3.77 (s,
3H), 3.76 (s, 1H), 3.70 (s, 1H), 3.69 (s, 3H); 13C NMR (100 MHz, CDC13), 6 169.3,167.1,
161.2, 158.7, 131.9, 130.1, 115.3, 104.2, 103.9, 98.8, 98.2, 55.4, 52.4, 52.1, 48.9, 48.2,
46.5, 45.0, 41.3. Exact mass calcd for Ci4Hi8ClN05Na [M+Naf, 338.0768. Found
338.0765.

DMBN ^
k

Cl _________,

A

NDMB

Nv ^
I
OMe

C 02Me

l-(2,4-dim eth oxybenzyl)-5-m eth oxy-l,6-d ih yd rop yrazin -2(3//)-oiie

(15).

To

a

solution of methyl 2-(2-chloro-Ar-(2,4-dimethoxybenzyl)acetamido)acetate (1.40 g, 4.44
mmol) dissolved in butanone (18 mL) was added NaN3 (0.58 g, 8.89 mmol) and the
mixture was brought to reflux with rapid stirring for 72 h. The mixture was cooled to rt,
filtered through celite and concentrated in vacuo to yield a yellow oil (1.1 g, 3.5 mmol,
79% yield), which was used without purification.
dissolved in toluene (28 mL) at rt and

PPI13

The intermediate product was

(0.97 g, 3.68 mmol) was added. After gas

evolution had steadied, the reaction vessel was heated to 90 °C for 19 h. The reaction
mixture was cooled to rt and concentrated in vacuo. The resulting residue was purified by
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flash column chromatography on silica gel (elution: 25% to 100% EtOAc in hexanes) to
provide 15 (0.54 g, 1.94 mmol, 56% yield), a light yellow solid: TLC (60% EtOAc in
hexanes), Rf: 0.12 (UV, CAM); IR (film) 2947, 2838, 2364, 1843, 1702, 1654, 1508,
1325, 1292, 1244, 1210, 1034, 938, 835, 756 cm'1; 'H NMR (400 MHz, CDC13) 7.22 (d,
J = 8.6 Hz, 1H), 6.47 (m, 1H), 6.45 (s, 1H), 4.58 (s, 2H), 4.17 (d ,./= 2.7, 2H), 3.85 (d, J
= 2.7, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 3.67 (s, 3H); 13C NMR (100 MHz, CDCI3), 5 166.3,
161.0, 159.0, 158.4, 131.8, 116.4, 104.7, 98.6, 55.6, 53.1, 50.7, 45.9, 43.3; Exact mass
calcd for Ci4H 18N20 4Na [M+Na]+, 301.1159. Found 301.1156.

General Procedure A for aldol condensation / alkene isomerization / DKP Diels-Alder
cycloaddition. To DMB protected diketopiperazine, 15, (1 equiv, 0.50 - 1.8 mmol) in
toluene (0.1 M) at -78 °C was added LiHMDS (1.0M in THF, 1.2 equiv) dropwise over 5
min by syringe. After stirring for 25 min at -78 °C the corresponding aldehyde (1.2
equiv) was added. The solution was stirred for 15 minutes, AC2O (1.3 equiv) was added at
-78 °C. The reaction vessel was warmed to rt, stirred for 4.5 h and DBU (2 equiv) was
added. The reaction vessel was heated to 100 °C for 19 h, and cooled to rt. The reaction
was quenched with saturated NH4CI (10 mL) and the aqueous phase was extracted with
EtOAc ( 3 x 1 0 mL). The combined organic layers were washed with brine, dried with
sodium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by
flash column chromatography.

General procedure B for deprotection of lactim O-methyl ether. To a solution of the
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cycloadduct (1 equiv, 0.09-0.45 mmol) in AcOH (0.1-0.2 M) was added KI (3 equiv) and
the mixture was heated at 100 °C for 2 h. The reaction was diluted with water (50 mL)
and extracted with EtOAc (3 x 150 mL). The combined organic layers were washed with
sodium bicarbonate (3 x 100 mL). The organic phase was washed with brine, dried with
sodium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by
flash column chromatography to afford the deprotected lactim ether.

General procedure C for acetylation. The lactam intermediate product (1 equiv, 0.070.15 mmol) was dissolved in a 1:1 solution of AC2O (0.5 mL) and pyridine (0.5 mL) and
heated at 100 °C for 16 h. The reaction was cooled to rt and concentrated. The resulting
residue was used directly in the subsequent cycloreversion reaction without purification.

General procedure D for cycloreversion to pyridone. The acylated lactam intermediate
(1 equiv, 0.03-0.15 mmol) was dissolved in toluene and heated for 1 h-1.5 h in the
microwave (300 W, power mode). The reaction solution was concentrated in vacuo and
the resulting residue was purified by flash column chromatography in silica gel to afford
the desired product.

NDMB
NDMB

OMe
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(3*S',9a5)-ll-(2,4-dimethoxybenzyl)-2-methoxy-3,9-dihydro-3,9a(epiniinomethano)indeno|2,l-/>]p\ridin-10-one (29): Produced following general
procedure

A

using

15

(50 mg, 1.8 mmol).

The product was purified by flash

chromatography on silica gel (elution: 25% to 100% EtOAc in hexanes) to yield the
purified product 29 (38 mg, 0.97 mmol, 54% yield) as a rust colored solid: TLC (60%
EtOAc in hexanes), Rfi 0.45 (UV, CAM); IR (film) 3002, 2945, 2837, 1684, 1615, 1589,
1507, 1466, 1334, 1306, 1266, 1210, 1160, 1036, 992, 934, 835, 756, 736 cm'1; *11 NMR
(400 MHz, CDCls) 7.39 (d, J= 7.42 Hz, 1H), 7.30 (t, J = 8.20 Hz, 2H), 7.18 (t, J = 7.42
Hz, 2H), 7.04 (d, J= 8.60 Hz, 1H), 6.47 (d, J= 5.47 Hz, 1H), 6.44-6.39 (m, 2H), 4.81 (d,
J = 5.47 Hz, 1H), 4.49 ( d , J = 14.85 Hz, 1H), 4.43 (d, J = 14.45 Hz, 1H), 4.37 (d, J =
17.58 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.70 (s, 3H), 3.50 (d, J = 17.6 Hz, 1H). 13C
NMR (100 MHz, CDC13) 8 174.7, 171.1, 160.6, 158.6, 158.5, 147.6, 133.6, 131.1, 129.9,
126.8, 126.1, 122.0, 116.7, 115.4, 104.0, 98.3, 79.0, 59.2, 55.3, 55.2, 43.7, 35.5; Exact
mass calcd for C23H2204N2Na [M+Na]+, 413.1472. Found 413.1468.

NDMB

NDMB
HN

(3£,9aA)-ll-(2,4-dimethoxybenzyI)-3,9-dihydro-3,9a-(epiminomethano)indeno[2,lb]pyridine-2,10(l//)-dione (30): Produced according to general procedure B using 29
(35 mg, 0.09 mmol). The product was obtained without purification (30 mg, 0.08 mmol,
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89% yield) as a brown solid: TLC (5% MeOH in Chloroform), R/i 0.53 (UV, CAM); IR
(film) 3203, 3072,2942,2841,1707, 1683, 1629,1589,1505,1466, 1303,1210,1158,
1039, 837, 754 cm'1; lH NMR (400 MHz, CDC13) 7.56 (br s, 1H), 7.34-7.29 (m, 3H),
7.25 (m, 1H), 7.07 (d, J = 7.82 Hz, 1H), 6.55 (d, J = 5.08 Hz, 1H), 6.41 (s, 1H), 6.39 (d, J
= 2.34 Hz, 1H), 4.61 (d, J= 14.46 Hz, 1H), 4.56 (dd, J= 5.47/1.56 Hz, 1H), 4.46 (d, J =
14.46 Hz, 1H) 4.21 (d, J = 18.0 Hz, 1H), 3.82 (s, 3H), 3.72 (s, 3H), 3.07 (d, J = 18.0, 1H).
13C NMR (100 MHz, CDC13) 6 172.4, 169.5, 160.8, 158.5, 156.1, 145.8, 133.0, 131.2,
130.4, 127.5, 126.0, 122.6, 117.5, 116.1, 104.0, 98.3, 69.5, 63.4, 55.3, 55.2, 44.2, 32.8;
Exact mass calcd for C22H2oN2 0 4Na [M+Na]+, 399.1315. Found 399.1311.

NDMB
NDMB

2-(2,4-dimethoxybenzyl)-2,9-dihydro-l//-mdeno[2,l-c]pyi'idm-l-oiie (31): Following
general procedure C, using 30 (25 mg, 0.066 mmol) the intermediate acylated product
was produced (19 mg, 0.047 mmol, 71% yield). This intermediate product was used (12
mg, 0.03 mmol) to produce 31 following general procedure D. The product was purified
by flash column chromatography on silica gel (elution: 30% to 70% EtOAc in hexanes)
to afford the product (0.006 g, 0.018 mmol, 60% yield) as a yellow solid: TLC (60%
EtOAc in hexanes), Rf: 0.40 (UV, KMn04); IR (film) 3067, 2962, 2839, 1700, 1507,
1464, 1277, 1267, 1210, 1038, 927, 828, 755 cm’1; *H NMR (400 MHz, CDC13) 7.69-

44

7.66 (m, 1H), 7.61-7.60 (m, 1H), 7.59 (d, J = 1.56 Hz, 1H), 7.42-7.37 (m, 2H), 6.64 (d, J
= 7.03 Hz, 1H), 6.48-6.45 (m, 2H), 5.17 (s, 2H), 3.86 (s, 2H), 3.85 (s, 3H), 3.79 (s, 3H),
2.05 (s, 1H). 13C NMR (100 MHz, CDC13) 5 161.1, 160.8, 158.6, 150.4, 145.2, 140.1,
137.9, 132.2, 130.9, 128.3, 126.7, 125.2, 121.1, 117.1, 104.3, 99.6, 98.5, 77.3, 55.4, 46.9,
35.6; Exact mass calcd for C2iHi9N 0 3Na [M+Na]+, 356.1257. Found 356.1253.

O
V ndm b
MeO-J_V

O
NDMB

Ph

OMe

(35,9a*S)-ll-(2,4-dimethoxybenzyl)-2-methoxy-4-phenyl-3,9-dihydro-3,9a(epiniinoniethano)indeno[2,l-/)|p\ridin-10-one (32): Prepared according to general
procedure A using 15 (100 mg, 0.36 mmol). The product was purified by flash
chromatography on silica gel (elution: 20% to 65% EtOAc in hexanes) to afford a clear
oil (120 mg, 0.25 mmol, 72% yield): TLC (40% EtOAc in hexanes), Rfi 0.40 (UV,
CAM); IR (film) 3022, 3009, 2945, 2836, 1696, 1617, 1589, 1510, 1465, 1331, 1210,
1166, 1035, 991, 835 cm-1; lU NMR (400 MHz, CDC13) 7.41 (d, J = 7.82 Hz, 1H), 7.38
(d, J = 7.82 Hz, 1H), 7.33-7.28 (m, 3H), 7.23 (d, J= 0.78 Hz, 1H), 7.21 (d, J = 0.78 Hz,
1H), 7.10 (d, J = 8.21 Hz, 1H), 7.08 (d, J = 8.21 Hz, 1H), 7.08 (d, J = 7.42 Hz, 1H), 7.01
(t, J= 7.03 Hz, 1H), 6.38 (dd, J = 8.2/2.3 Hz, 1H), 6.28 (d, J = 2.3 Hz, 1H), 5.00 (s, 1H),
4.67 (d, J = 14.5 Hz, 1H), 4.43 (d, J = 14.5 Hz, 1H), 4.41 (d, J = 17.8 Hz, 1H), 3.76 (s,
3H), 3.75 (s, 3H), 3.58 (s, 3H); 13C NMR (100 MHz, CDC13) 5 174.8, 170.9, 160.8,
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158.4, 149.9, 147.8, 135.4, 133.8, 132.5, 131.5, 129.7, 128.4, 127.8, 127.3, 126.4, 126.0,
122.2, 116.6, 104.3, 98.3, 79.5, 64.6, 55.28, 55.27, 54.9, 43.2, 35.5; Exact mass calcd for
C29H26N204Na [M+Na]+, 489.1785. Found 489.1777.

NDMB

NDMB
Ph

HN

(3S,9a5)-ll-(2,4-dimethoxybenzyl)-4-phenyl-3,9-dihydro-3,9a(epimin<>inethano)indeno[2,l-/>|pyridine-2 , 10(l/y)-dione

(33):

Following

general

procedure B, 32 (90 mg, 0.19 mmol) produced 33 without purification (88 mg, 0.188
mmol, 99% yield) as a yellow oil: TLC (40% EtOAc in hexanes), R/: 0.18 (UV, CAM);
IR (film) 3224, 3068, 2939, 2837, 1710, 1613, 1588, 1509, 1465, 1294, 1266, 1210,
1159, 1036, 936, 826, 761 cm’1; lU NMR (400 MHz, CDC13) 8.38 (br s, 1H), 7.40 (d, J =
7.8 Hz, 1H), 7.31-7.23 (m, 3H), 7.15 (d, J = 8.2 Hz, 2H), 7.07-7.01 (m, 4H), 6.38 (dd, J
= 8.4/2.1 Hz, 2.3, 1H), 6.24 (d,

2.3 Hz, 1H), 4.59 (d, J = 14.5 Hz, 1H), 4.79 (s, 1H),

4.45 (d, J = 14.1 Hz, 1H), 4.25 (d, J= 18.0 Hz, 1H), 3.76 (s, 3H), 3.49 (s, 3H), 3.16 (d, J
= 11.6, 1H). 13C NMR (100 MHz, CDC13) 6 173.1, 169.3, 161.0, 158.5, 147.3, 146.0,
134.9, 134.7, 133.4, 131.7, 130.2, 128.4, 128.3, 127.3, 127.1, 126.0, 122.8, 116.2, 104.4,
98.4, 69.9, 68.9, 55.3, 54.9, 43.7, 32.9; Exact mass calcd for C28H24N204 Na [M+Na]+,
475.1628. Found 475.1625.
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2-(2,4-dimethoxybenzyl)-4-phenyl-2,9-dihydro-l//-mdeno[2,l-c]pyridm-l-one (34):
Following general procedure C, using 33 (70 mg, 0.15 mmol) the intermediate acylated
product was produced (75 mg, 0.15 mmol, 100% yield). This intermediate product was
used (70 mg, 0.15 mmol) to produce 34 following general procedure D. The product was
purified by flash column chromatography on silica gel (elution: 20% to 80% EtOAc in
hexanes) to afford the product (50 mg, 0.12 mmol, 90% yield) as a bright yellow solid:
TLC (60% EtOAc in hexanes), R/i 0.45 (UV, CAM); IR (film) 3053, 3001, 2835, 2361,
1648, 1612, 1590, 1505, 1457, 1430, 1377, 1287, 1266, 1207, 1158, 1125, 1034, 941,
834, 754, 704 cm’1; *H NMR (400 MHz, CDC13) 7.57 (d, J= 7.42 Hz, 1H), 7.48-7.39 (m,
4H), 7.32 (t, y = 1.17 Hz, 2H), 7.26 (d, J = 2.74 Hz, 1H), 7.09 (t, J = 7.82 Hz, 2H), 6.97
(d, J = 7.42 Hz, 1H), 6.48 (s, 1H), 6.45 (s, 1H), 5.20 (s, 2H), 3.90 (s, 2H), 3.81 (s, 3H),
3.78 (s, 3H). 13C NMR (100 MHz, CDC13) 6 160.8, 158.5, 148.3, 145.6, 140.1, 137.2,
136.6, 132.2, 131.3, 129.7, 128.4, 127.8, 127.8, 126.2, 124.9, 123.7, 117.6, 117.0, 104.2,
98.5, 55.32, 55.27, 55.25, 47.0, 35.7; Exact mass calcd for C27H23N 0 3Na [M+Na]+,
423.1570. Found 423.1564.
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4-phenyl-2,9-dihydro-l//-indeno[2,l-c]pyridin-l-one

(38):

The

DMB

protected

pyridone, 34, (10 mg, 0.024 mmol) was dissolved in a 2:1 CH2CI2.TFA (0.9 mL) and
heated on temp mode in the microwave to 120 °C for 10 min. The product was purified
by flash column chromatography on silica gel (elution: 0% to 15% MeOH in CHC13) to
afford the product (4.9 mg, 0.024 mmol, 78% yield) as a white solid: TLC (60% EtOAc
in hexanes), Rf: 0.35 (UV, CAM); IR (film) c m 12984, 1919, 1710, 1826, 1639, 1607,
1495, 1423, 1282, 1149, 1018, 945, 887; 'H NMR (400 MHz, CDCI3) 7.63 (d, J = 7.4
Hz, 1H), 7.52 (m, 4H), 7.45 (m, 2H), 7.37 (t, J = 7.4Hz, 1H), 7.29 (s, 1H), 7.13 (t, 7.6
Hz, 1H), 6.98 (d, J =7.815, 1H), 3.90 (s, 1H). 13C NMR (100 MHz, CDCI3) 5 161.2,
151.0, 145.0, 139.2, 135.5, 132.7, 130.4, 129.3, 128.24, 128.21, 127.8, 126.1, 124.6,
123.7, 119.6, 34.5; Exact mass calcd for Ci8Hi3NONa [M+Na]+, 282.0889. Found
282.0891.

General Procedure - Proline derived DKP
General Procedure E for aldol condensation / alkene isomerization / DKP Diels-Alder
cycloaddition.To a solution of diketopiperazine 14 (1 equiv, 0.89-1.3 mmol) in toluene
(0.1 M) at

-78 °C was added LiHMDS (1 M in THF, 1.1 equiv) dropwise and the

solution was stirred at -78 °C for 25 minutes. The corresponding aldehyde (1.2 equiv)
was added and stirred for 15 minutes, followed by addition of AC2O (1.3 equiv). The

reaction mixture was warmed to rt and stirred for 4.5 h after which DBU (2 equiv) was
added dropwise and the mixture was heated to 100 °C for 19 h.

The reaction was

quenched with saturated NH4CI and the aqueous phase was extracted with EtOAc (3 x 1 0
mL). The organic layer was washed with brine (10 mL), dried with sodium sulfate,
filtered, and concentrated in vacuo. The resulting residue was purified by flash column
chromatography (elution: 25% to 100% EtOAc in hexanes) to afford the desired product.

General Procedure F for deprotection of lactim O-methyl ether. The cycloadduct (1
equiv, 0.03-0.51 mmol) was dissolved in AcOH (0.05 M), KI (3 equiv) was added and
the mixture was stirred at 100 °C for 2 h. The resulting mixture was quenched with water
and the aqueous phase was extracted with EtOAc (3 x 150 ml) and then washed with
sodium bicarbonate (3 x 100 ml). The organic phase was washed with brine, dried with
sodium sulfate, filtered, and concentrated in vacuo. The product was purified by flash
column chromatography (elution: 25% to 100% EtOAc in hexanes) to afford the desired
product.

General Procedure G for acetylation. The lactam bridge cycloadduct (1 equiv, 0.9-0.32
mmol) was dissolved in a 1:1 solution of AC2O (0.5 M) and pyridine (0.5 M) and stirred
at 100 °C for 24 h. The solution was concentrated and submitted to the next step without
purification.

General Procedure H for cycloreversion to pyridone. The protected cycloadduct (1
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equiv, 0.37-0.38 mmol), in toluene, was heated in the microwave (300 W, Power Mode)
for 1 h. The solution was concentrated in vacuo and the resulting residue was purified by
flash column chromatography in silica gel (elution: 40% to 100% EtOAc in hexanes, 0%
to 20% MeOH in chloroform) to afford the desired product.

i p
OMe

12-methoxy-2,3-dihydro-l//-5a,lla-(azenometheiio)mdeiio[2,l:/lHidolizm-5(6i/)-oiie
(26): Produced following general procedure E using 14 (150 mg, 0.89 mmol).

The

product was purified by flash column chromatography on silica gel (elution: 30% to
100% EtOAc in hexanes) to afford the product (115 mg, 0.41 mmol, 46% yield) as a
brown oil: TLC (40% EtOAc in hexanes), R/i 0.20 (UV, KMn04 ); IR (film) 3269, 2984,
2951, 2879, 1735, 1617, 1454, 1437, 1339, 1221, 1175, 1107, 1041, 1006, 841, 755 cm'1;
'H NMR (400 MHz, CDCI3) 7.39 (d, J= 7.42 Hz, 1H), 7.34 (d, J= 7.82 Hz, 1H), 7.30 (d,
J = 7.43 Hz, 1H), 7.20 (t, J = 7.42 Hz, 1H), 6.45 (s, 1H), 4.32 (d ,J = 17.6 Hz, 1H), 3.77
(s, 3H), 3.51 (d, J = 18.0 Hz, 1H), 3.43-3.39 (m, 1H), 3.27-3.22 (m, 1H), 2.83-2.76 (m,
1H), 2.31-2.24 (m, 1H), 2.18-2.12 (m, 1H), 2.09-2.04 (m, 1H). 13C NMR (100 MHz,
CDCI3) 8 174.8, 169.5, 159.8, 147.5, 133.4, 129.8, 126.8, 126.0, 121.9, 119.7, 80.4, 70.4,
55.5, 42.1, 34.9, 27.0, 25.4; Exact mass calcd for CnHi6N 2 0 2Na [M+Na]+, 303.1104.
Found 303.1102.
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2,3-dihydro-l//-5a,lla-(epimmomethano)indeno[2,l:/]iiidolizme-5,12(6i/)-dioiie
(27): Produced following general procedure F using 26 (58 mg, 0.21 mmol). The product
was obtained without purification (50 mg, 0.19 mmol, 98% yield) as a dark brown solid:
TLC (60% EtOAc in hexanes), R/i 0.30 (UV, KMn04); IR (film) 3229, 3070, 2976,
2942, 2879, 1691, 1465, 1393, 1326, 1260, 1195, 1156, 1086, 754, 668 cm'1; lU NMR
(400 MHz, CDC13) 7.66 (br. s, 1H), 7.38 (d, J = 7.82, 1H), 7.36-7.30 (m, 2H), 7.25 (m,
1H), 6.50 (s, 2H), 4.16 (d, J = 18.0, 1H), 3.51 (m, 1H), 3.30 (m, 1H), 3.12 (d, J = 17.6,
1H), 2.86 (m, 1H), 2.18-2.03 (m, 2H). 13C NMR (100 MHz, CDC13) 6 173.6, 168.1,
157.4, 146.2, 133.3, 130.7, 127.9, 126.4, 122.9, 122.0, 73.0, 70.7, 43.3, 32.8, 27.3, 25.5;
Exact mass calcd for Ci6Hi4N 202Na [M+Na]+, 289.0947. Found 289.0946.

HN

2,3-dihydro-l//-indeno[2,l-/]indolizin-5(6//)-one (28): Following general procedure F,
using 27 (26 mg, 0.09 mmol) the intermediate acylated product was produced (30 mg,
100% yield).

This intermediate product

was used (30 mg, 0.26 mmol) to produce
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28 following general procedure H. The product was purified by flash column
chromatography on silica gel (elution: 50% to 100% EtOAc in hexanes and 0% to 20%
MeOH and EtOAc) to afford the product (18 mg, 0.08 mmol, 83% yield) as a dark brown
solid: TLC (60% EtOAc in hexanes), Rf. 0.10 (UV, KMn04); IR (film) 3420, 3053, 2964,
2896, 1657, 1570, 1457, 1295, 1296, 1241, 1152, 1096, 1019, 803, 772, 752 cm’1; !H
NMR (400 MHz, CDC13) 7.68 (m, 1H), 7.41-7.39 (m, 2H), 7.28 (d, J = 2.74, 1H), 6.62
(s, 1H), 4.24-4.20 (m, 2H), 3.83 (s, 2H), 3.18-3.14 (t, J = 7.23, 2H), 2.29-2.23 (m, 2H)
13C NMR (100 MHz, CDC13) 6 160.5, 151.9, 150.7, 145.8, 140.4, 128.5,128.1, 126.9,
125.5, 121.3, 95.5, 48.6, 35.2, 32.1, 22.2; Exact mass calcd for Ci5Hi3NONa [M+Naf,
246.0889. Found 246.0887.

O
Ph

N
OMe

12-methoxy-ll-phenyl-2,3-dihydro-l/f-5a,lla-(azenometheno)indeno[2,lJ] indolizm-5(6//)-one (35): Produced following general procedure E using 14 (220 mg,

1.3 mmol). The product was purified by flash column chromatography on silica gel
(elution: 20% to 80% EtOAc in hexanes) to afford the product (200 mg, 0.56 mmol, 43%
yield) as a yellow oil: TLC (40% EtOAc in hexanes), R/: 0.20 (UV, KMn04); IR (film)
3052, 2883, 1691, 1622, 1399, 1324, 1287, 1174, 1129, 1007, 755, 743, 702 cm'1; 1H
NMR (400 MHz, CDC13) 7.43-7.28 (m, 2H), 7.41-7.36 (m, 2H), 7.24-7.18 (m, 3H), 6.95
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(s, 2H), 4.37 (d, J= 18.0 Hz, 1H), 3.87 (s, 3H), 3.53 (d, J = 18.0 Hz, 1H), 3.48-3.46 (m,
1H), 3.27-3.24 (m, 1H), 2.58-2.55 (m, 1H), 2.02-1.93 (m, 3H). 13C NMR (100 MHz,
CDCls) 5 175.2, 169.9, 152.9, 147.6, 134.9, 134.0, 133.98, 132.0, 129.6, 128.7, 128.6,
128.0, 126.5, 125.9, 122.3, 79.9, 73.4, 55.9, 53.4, 42.6, 35.0, 25.5, 22.0; Exact mass calcd
for C23H2oN202Na [M+Na]+, 379.1417. Found 379.1414.

HN

Ph

Ph

1l-phenyl-2,3-dihydro-lH -5a9l 1a-(epim inomethano)indeno [2,1:/] indolizine5,12(6tf)-dione (36): Produced following general procedure F using 35 (431 mg, 1.2
mmol). The product was purified by flash column chromatography on silica gel (elution:
25% to 100% EtOAc in hexanes) to afford the product (355 mg, 1.0 mmol, 87% yield) as
a tan solid: TLC (60% EtOAc in hexanes), Rfi 0.30 (UV, KMn04); IR (film) 3229, 3057,
2979, 1959, 2882, 1669, 1467, 1394, 1331, 1313, 1266, 1199, 1154, 1074, 1031, 734, 704
cm'1; lU NMR (400 MHz, CDC13) 8.32 (s, 1H), 7.26-7.37 (m, 3H), 7.32 (d, J = 7.82 Hz,
1H), 7.27-7.25 (m, 1H), 7.23-7.20 (m, 2H), 7.03-6.97 (m, 2H), 4.23 (d, J = 18.0 Hz,
1H), 3.57-3.53 (m, 1H), 3.36-3.30 (m, 1H), 3.20 (d, J = 18.4 Hz, 1H), 2.64-2.59 (m,
1H), 1.97-1.84 (m, 3H). 13CNMR(100 MHz, CDC13) 6 173.9, 168.1, 150.2, 145.9, 136.7,
133.7, 133.5, 130.0, 128.4, 128.3, 127.2, 125.9, 123.0, 75.8, 70.2, 43.3, 32.5, 25.5, 25.2;
Exact mass calcd for C22HigN20 2Na [M+Na]+, 365.1260. Found 365.1260.
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ll-phenyl-2,3-dihydro-lJHr-indeno[2,l-/|indolizm“5(6/0"olie (37): Following general
procedure F, using 36 (110 mg, 0.32 mmol) the intermediate acylated product was
produced (115 mg, 0.30 mmol, 94% yield). This intermediate product was used (115 mg,
0.30 mmol) to produce 37 following general procedure H. The product was purified by
flash column chromatography on silica gel (elution: 40% to 100% EtOAc in hexanes and
0% to 20% MeOH and EtOAc) to afford the product (74 mg, 0.25 mmol, 83% yield) as a
mustard yellow solid: TLC (60% EtOAc in hexanes), R/i 0.45 (UV, KMn0 4 ); IR (film)
3411, 3051, 2980, 2896, 1642, 1623, 1564, 1531, 1495, 1442, 1387, 1285, 1208, 1165,
1029 c m 1; 'H NMR (400 MHz, CDCI3) 7.57 (d, J = 7.42 Hz, 1H), 7.52-7.49 (m, 3H),
7.37-7.34 (m, 2H), 7.29 (m, 1H), 7.05 (t, J = 7.82 Hz, 1H), 6.63 (d, ./= 7.82 Hz, 1H),
4.34-4.30 (m, 2H), 3.89 (s, 2H), 2.93 (t, J = 7.03 Hz, 2H), 2.25-2.17 (m, 2H). 13C NMR
(100 MHz, CDCI3) S 159.5,149.9, 148.0, 145.8, 140.3,136.4, 130.1, 128.8,128.0, 127.7,
126.2, 125.0, 123.7, 113.2, 77.3, 48.8, 34.9, 31.0, 21.8; Exact mass calcd for
C2iHi7NONa [M+Na]+, 322.1202. Found 322.1200.
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(6*S',8aS)-dimethyl

6-benzyl-9-methoxy-5-oxo-2,3>5,6-tetrahydro-l//-6,8a-

(azenometheno)indolizme-7,8-dicarboxylate (40): To proline DKP, 14, (1.2 mmol) in
toluene at -78 °C was added LiHMDS (1.0M in THF, 1.1 equiv.) dropwise over 5
minutes by syringe. After stirring for 25 minutes at -78 °C, benzaldehyde (1.2 equiv.)
was added to the solution. AC2O (1.3 equiv.) was added dropwise at -78 °C, and the
solution was allowed to warm to room temperature while stirring. DBU (2 equiv.) was
added and the mixture stirred at rt for 16 hours. The reaction was washed with NH4CI (20
mL) and extracted with EtOAc (10 mL x 3). The organic layer was washed with brine (10
mL), dried with Na2S0 4 , and then concentrated in vacuo. To the product (3.1 mmol) in
DMF (20 mL) was added DMAD (1.2 equiv.). The reaction mixture was concentrated
and purified by flash chromatography on silica gel (elution: 10%-50% EtOAc in
hexanes) to afford a pale yellow solid (390 mg, 37% yield).

TLC (60% EtOAc in

hexanes), Rfi 0.60 (KMn04); IR (film) cm-13036, 2990, 2959, 2890, 1740, 1694, 1636,
1496, 1434, 1388, 1206, 1144, 1097, 981, 1080, 894, 792, 698; H NMR (400 MHz,
CDCI3) 7.57-7.55 (d, 2H, J= 7.0 Hz), 7.27-7.16 (m, 3H), 3.88 (s, 3H), 3.71 (s, 3H), 3.67
(d, 1H, J = 15.4 Hz), 3.45 (s, 3H), 3.18 (m, 1H), 2.80 (m, 1H), 2.49 (m, 1H), 2.04 (m,
1H), 1.91 (m, 1H); 13C NMR (100 MHz, CDCI3) 8 174.2, 168.2, 164.9, 162.4, 152.3,
138.0, 136.6, 130.8, 127.5, 126.3, 74.3, 68.3, 56.4, 52.3, 52.2, 43.0, 35.0, 25.9,
25.2; HRMS (ES+): Exact mass calcd for Czi^NzOeNa [M+Na]+ 421.1370 Found

421.1365.

MeO.

C 0 2Me

CO?Me

Ph

Ph

dimethyl 2-benzyl-5-(2-isocyanatoethyl)-6-methoxypyridine-3,4-dicarboxylate (41):
Cycloadduct 40 (20 mg, 0.05 mmol) in toluene (2 mL) was heated in the microwave at
300 W for 1 hr 15 min. The reaction was concentrated to afford a clear colorless oil (15
mg, 75% yield). TLC (60% EtOAc in hexane), R/: 0.70 (KMn0 4 ); IR (film) cm-1 2952,
2277, 1735, 1653, 1576, 1440, 1297, 1262, 1194, 1089, 1075, 668; *H NMR (400MHz,
CDCls) 7.31-7.26 (m, 3H), 7.22-7.16 (m, 2H), 4.29 (s, 2H), 3.96 (s, 3H). 3.89 (s, 3H),
3.80 (s, 3H), 3.32-3.30 (t, J = 6.4 Hz, 2H), 2.63-2.60 (t, J = 7.6 Hz, 2H), 1.88-1.83
(quintet, J = 7.0 Hz, 2H); 13C NMR (100 MHz, CDC13) 167.8, 167, 3, 162,7, 157.5,
143.7, 139.4, 129.4, 128.6, 128.4, 126.5, 122.2, 119.1, 117.7, 54.5, 53.0, 52.7, 42.9, 42.0,
30.9, 24.6; HRMS (ES+): Exact mass calcd for C21H22N 2O6 421.1370 Found 421.1366.

(65,8a1S)-dimethyl

6-benzyl-5,9-dioxo-2,3,5,6-tetrahydro-l/f-6,8a-

(epimmomethano)indolizine-7,8-dicarboxylate (42): Cycloadduct 40 (250 mg, 0.63
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mmol) in AcOH was added KI (3 equiv.) and stirred at 115 °C for 30 minutes. The
reaction was diluted with water (50 mL) and Na2C03 (10%, 20 mL) and extracted with
EtOAc (3 x 20 mL). The organic layer was washed with NaHC03 with thiosulfate (20
mL), brine (20 mL), dried with Na2S0 4 , and concentrated in vacuo to afford a pale
yellow powder (240 mg,

100%). TLC (60% EtOAc in hexane), R/: 0.30

(KMn04); IR (film) cm-1 3220, 2955, 1715, 1670, 1497, 1405, 1283, 1146, 1039, 970; lH
NMR (400MHz, CDC13) 7.39-7.27 (m, 5H), 5.86 (s, 1H), 3.92 (d, 1H, J = 15 Hz), 3.82
(s, 3H), 3.80 (s, 3H), 3.52 (m, 1H), 3.34-3.27 (m, 2H), 2.83 (m, 1H), 2.30 (m, 1H), 2.092.00 (m, 2H); 13C NMR (100 MHz, CDC13) 5169.6, 166.1, 163.7, 162.7, 147.7, 142.6,
133.4, 130.6, 129.2, 127.8, 70.9, 65.3, 52.8, 52.8, 43.8, 32.4, 25.7, 24.9; HRMS (ES+):
Exact mass calcd for C20H20N 2O6 407.1214 Found 407.1209.

O

dimethyl 6-benzyl-5-oxo-l,2 ,3,5-tetrahydroindolizine-7,8-dicar boxy late (43): The
DMAD lactam cycloadduct, 42, (20 mg, 0.05 mmol) in AC2O (2 mL) was heated in a
sealed tube to 140 °C for 17 hr and cooled to rt. The mixture was washed with NH4CI (20
mL) and extracted with EtOAc (3 x 10 mL). The organic layer was washed with brine (10
mL), dried with Na2S04, and then concentrated in vacuo. The product was purified by
flash column chromatography (elution: 30-80% EtOAc in hexanes) to afford a white solid
(15 mg, 84% yield). TLC (60% EtOAc in

hexane), Rf: 0.20 (KMnO„); IR (film) cm"1
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2952, 1740, 1713, 1652, 1600, 1540, 1416, 1382, 1295, 1240, 1168, 1093, 1002, 737; ‘H
NMR (400MHz, CDC13) 7.35-7,34 (m, 2H), 7.26-7.24 (m, 2H) 7.15 (m, 1H), 4.16-4.13
(t, 2H, J = 7.6Hz), 3.88 (s, 2H), 3.82 (s, 6 H), 3.50 (t, 2H, J= 7.8Hz), 2.19 (quintet, 2H, J
= 7.8Hz); 13C NMR (100 MHz, CDCI3) 167.9, 164.6, 161.1, 155.8, 142.2, 138.6, 129.0,
128.1, 126.6, 126.2, 102.7, 77.3, 52.5, 52.1, 49.7, 34.5, 33.6, 20.5; HRMS (ES+): Exact
mass calcd for C 19H 19NO5, 364.1155. Found 364.1151.

O

O
^

NDMB

N
OMe

}

MeOTMS
^

(3^,7a*S)-9-(2,4-dimethoxybenzyl)-2-methoxy-4-(trimethylsilyl)-3,5,6,7-tetrahydro3,7a-(epimmomethano)cyclopenta[£]pyridm-8-one (46): Prepared according to general
procedure A using 15 (200 mg, 0.72 mmol). The product was purified by flash
chromatography on silica gel (elution: 30% to 90% EtOAc in hexanes) to afford a yellow
oil (260 mg, 87% yield): TLC (40% EtOAc in hexanes), R/i 0.15 (UV, CAM); IR (film)
2959, 2839, 1679, 1615, 1576, 1506, 1459, 1405, 1333, 1250, 1140, 1035, 867, 843; (400
MHz, CDCI3) 6.96 (dd, J =8.42/1.6Hz, 1H), 6.40 (m, 2H), 4.66 (d, J = 2.0 Hz, 1H), 4.41
(dd, J = 14.7/1.4Hz, 1H), 4.19 (dd, J = 14.7/1.4 Hz, 1H) 3.784-3.782 (d, J = 2.0 Hz, 3H),
3.76-3.75 (d, J= 0.8 Hz, 3H), 3.624-3.622 (d, 0.8 Hz., 3H), 2.98 (m, 1H), 2.42 (m, 1H),
2.31 (m, 1H), 2.08-2.00 (m, 2H), 1.83 (m, 1H) 0.00 (s, 9H); 13C NMR (100 MHz, CDC13)
5 174.8, 170.5, 169.4, 160.4, 159.2, 130.8, 129.8, 116.7, 104.0, 98.1, 81.2, 79.0, 60.6,
55.1, 55.0, 54.7, 42.7, 29.5, 28.8, 26.3, -1.8. HRMS (ES+): Exact mass calcd for
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Ci4H24 0 2Si [M+Na]+, 275.1438. Found 275.1439.

Ov

^NDMB

NDMB

H N yO ^-T M S

(3/?,7aiS)-9-(2,4-dimethoxybenzyl)-4-(trimethylsilyl)-3,5,6,7-tetrahydro-3,7a(epiminomethano)cyclopenta[/>]pyridine-2,8(l//)-dione

(47):

Following

general

procedure B, 46 (200 mg, 0.48 mmol) produced 47 without purification (170 mg, 88 %
yield) as a pale brown solid: TLC (60% EtOAc in hexanes), R/: 0.4 (UV, KMn04 ); IR
(film) cm'13516, 3209, 2945, 2834, 1680, 1614, 1507, 1447, 1292, 1251, 1209, 1036; lH
NMR (400 MHz, CDC13) 8.04 (br. s, 1H), 7.03 (dd, J = 7.8/2.7Hz, 1H), 6.4-6.40 (m,
2H), 4.45 (d, J = 2.34, 2H), 4.08 (t, J = 1.8Hz, 1H), 3.79-3.77 (t, J = 3.7 Hz, 6 H), 2.79
(m, 1H), 2.44-2.40 (m, 2H), 2.09-2.03 (m, 2H), 1.91 (m, 1H), 1.77 (m, 1H), 0.00 (d, J =
3.1 Hz, 9 H); 13C NMR (100 MHz, CDC13) 5 173.2, 169.4, 166.4, 160.8, 158.6, 134.1,
131.1, 116.4, 104.4, 98.5, 71.3, 65.5, 55.4, 55.3, 43.2, 29.0, 27.6, 26.6. HRMS (ES+):
Exact mass calcd for C21H28N20 4Si [M+Na]+, 423.1711. Found 423.1714.
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ndm b

NDMB

° ? 7r* ^s ^L— TMS
HN—
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2-(2,4-dimethoxybenzyI)-4-(trimethylsilyl)-2,5,6,7-tetrahydro-l//cyclopenta[c]pyridin-l-one (48): Following general procedure C, using 47 (110 mg,
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0.28 mmol) the intermediate acylated product was produced (118 mg, 97% yield). This
intermediate product was used (118 mg, 0.27 mmol) to produce the pyridone, 48,
following general procedure D. The product was purified by flash column
chromatography on silica gel (elution: 50% to 100% EtOAc in hexanes) to afford the
product (85 mg, 0.24 mmol, 89% yield) as a brown oil: TLC (60% EtOAc in hexanes),
Rf: 0.1 (UV, KMn04); IR (film) cm-13168, 2963, 2834, 2475, 2064, 1699, 1636, 1496,
1456, 1374, 1319, 1253, 1041; ‘H NMR (400 MHz, CDC13) 7.43 (d, J = 9.8 Hz, 1H),
7.41 (s, 1H), 6.43 (d, J = 2.0, 2H), 5.05 (s, 2H), 3.83 (s, 3H), 3.76 (s, 3H), 2.82-2.76
(quartet, J = 7.8 Hz, 4H), 2.03-1.99 (quintet, 7.6 Hz, 2H) ; 13C NMR (100 MHz, CDCI3)
8 161.0, 160.6, 158.4, 157.9, 141.8, 132.5, 131.6, 117.4, 111.2, 105.0, 98.2, 55.3, 55.1,

46.4, 34.9, 29.5, 23.4, -0.9. HRMS (ES+): Exact mass calcd for C2oH27N0 3 Si [M+Na]+,
380.1652. Found 380.1655.
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Chapter 3
Synthesis of Louisianin B
Isolation of Louisianins
In 1995, Omura and co-workers isolated Louisianins A through D from a cultured
broth of Streptomyces sp. WK-4028 from a soil sample collected in Louisiana.1
Louisianins A (1) and B (2) are pyridones, while Louisianins C (3) and D (4) are
pyridines (Figure 3.1). Members of this small family of molecules share a common
feature that the pyridine or pyridone core is fused with a five-membered ring at the C-3
and C-4 positions. Louisianin B has a hydroxyl group instead of a carbonyl on the
cyclopentane ring, giving it a stereocenter; however, Omura did not determine the
stereochemistry of the natural product.

NH

NH

HO

Louisianin A (1)

Louisianin B (2)

Louisianin C (3) Louisianin D (4)

Figure 3.1 Louisianin family structures

Louisianin A has been shown to inhibit the growth of SCI 15 cancer cells, a class
of androgen-dependent mouse mammary tumor cells. Louisianins C and D are isolated in
very small amounts. To acquire sufficient material for the determination of biological
activity, Omura demonstrated that the

conversion
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of louisianin

A to

both

louisianin C and D was possible in 51% and 43% yields, respectively. After obtaining
ample amounts of the pyridine natural products, it was determined that louisianin C and
D are suppressors of vascular endothelial cells.

Previous Syntheses of Louisianin Family
Kelly, in 2003, completed the first synthesis of a member of the louisianin family,
louisianin C (Scheme 3.1). Beginning with a symmetrical 3,5-dibromopyridine, Kelly
treated the pyridine with LDA and trapped the lithiated intermediate with TMS Cl to form
5. A double Stille coupling produced allylated pyridine 6 . Hydroboration and oxidation of
one allyl residue preceded formation of alcohol 7 followed by oxidation using
iodoxybenzoic acid, IBX. TBAT was then used to fluorinate the TMS group, forming 8
which possesses more nucleophilic character at position 4 of the pyridine ring. This set
up for subsequent desilylation and cyclization through nucleophilic addition into the
aldehyde. An oxidation using CrC>3 provided the final product, louisianin C (3), in six
steps with 11% overall yield. Kelly demonstrated how functionalization of a
commercially available symmetric pyridine could construct the desired natural product.
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TMS
BrvY ^ V " Br LDA, TMSCI^ B r ^ k / B r
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N

THF, -78 °C
83%

li, J

TMS

DMF, 100 °C
96%

N

TMS

^ ^ SnB u3
Pd(PPh3)2Cl2 ^

1) BF3OEt2, rt
2) 9-BBN, 0 °C
3) TMEDA
4) H20 2> NaOH, 0 °C
t
43%

O
IBX

OH

DMSO, rt
82%

TBAT
MeCN, rt
54%

7
HO
SiMeCr03 _
pyridine, r t 75%
Louisianin C (3)

Scheme 3.1 Kelly’s synthesis of louisianin C
In 2006, Chang reported the first synthesis of louisianin A from a starting
asymmetrical 2-chloro-4-cyanopyridine

(Scheme 3.2).4 The

C-3 position was

deprotonated using LDA and subsequently iodinated. A Heck reaction was then utilized
to couple the pyridine to methyl acrylate. This product 9 was then hydrogenated to afford
the saturated chain, which would later be transformed into the fused cyclopentane ring
system. A bromine was next attached at C-5, setting up for a Stille coupling to add the
pendant allyl group onto the pyridine ring to form 10. Finally, cyclization occurred
through a Dieckmann condensation, in which nucleophilic attack on the nitrile closes the
cyclopentanone ring and is followed by decarboxylation to form the final pyridone,
louisianin A (1), in seven overall steps with

24% yield.
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H
Lousianin A (1)

Scheme 3.2 Chang’s synthesis of louisianin A

Previous syntheses of this family of molecules involved using a commercially
available pyridine as the starting material. In 2006, Chang was able to synthesize
louisianin D (4) in 10 steps with 20% yield overall. This was achieved by accessing a
glutarimide through a [3+3] annulation of an a-sulfonyl acetamide with an a,(3unsaturated ester.5 Subsequent aromatization and allylation were required to achieve the
desired natural product.
The previous syntheses were able to form louisianin A, C, and D. Louisianin B
had not been synthesized until Taylor, in 2009, was able to access all four members of the
louisianin family through an inverse electron demand Diels-Alder.6 A 1,2,4-triazine was
used as the azadiene for the Diels-Alder. First, Taylor had to construct the triazine core
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(Scheme 3.3). This required the condensation between 11 and 12 to form an amidrazone
hydrazone, which underwent subsequent oxidative cyclocondensation to produce the
needed triazine, 13. This set up for the cycloaddition with an enamine, which is followed
by cycloreversion in one pot with loss of diatomic nitrogen. This successfully constructed
the pyridine core that was the common intermediate 14 on route to all four louisianin
family members.

OH
1) EtOH,
rt, 2 h
tol, microwave
1 2 0 °C, 1 h
89%
SPh
11

12

13

14

Scheme 3.3 Taylor’s route to common intermediate

For the route to louisianin C and D, decarbonylation occurred after washing with
dilute HC1, and oxidation of the cyclopentane ring was accomplished using LiHMDS and
molecular oxygen to produce benzylic alcohol 15 (Scheme 3.4). The sulfide was then
oxidized to the sulfoxide using m-CPBA, followed by heating to eliminate the
benzenesulfonic acid. The secondary alcohol was then oxidized to reveal louisianin C (3)
in 11 steps with 7.2% overall yield. Louisianin C was then converted into louisianin D (4)
through an isomerization of the allyl group using 7-methyl-1,5,7-triazabicyclo[4.4.0]dec5-ene (MTBD) in toluene and heating to 80 °C. Louisianin D was synthesized in 12 steps
with a 5.6% yield overall.
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C 0 2Et
1

dil. aq. HCI,
microwave,
185 °C, 1 h

LHMDS, P(OEt)3,
0 2> THF, -5 °C 8 h

83%

80%
OH

SPh

SPh
15
i) m-CPBA, CH2CI2,
-78 °C 1 h
ii) C aC 03, xylene,
160 °C, 18 h
76%

SPh

14

MTBD, tol,
80 °C 6 h

p c c / ai 2o 3,
CH2CI2, rt, 3 h

78%

80%

N

OH
Louisianin D (4)

Louisianin C (3)

Scheme 3.4 Taylor’s synthesis toward louisianin C and D

After producing the two pyridine natural products, Taylor aimed to synthesize the
pyridones, louisianin A (1) and B (2). Using common intermediate 14, Taylor converted
the ethyl ester into an acid using TMSOK (Scheme 3.5). The acid underwent radical
decarboxylative halogenation through a Barton ester intermediate. An oxidation similar
to that used toward louisianin C and D installed the benzylic alcohol functionality. A
Parikh-Doering oxidation was then used to convert this benzylic alcohol into a ketone.
Next, treatment with acetic acid and water hydrolyzed the chloropyridine to form the
desired pyridone core 16. A similar approach for the allylation was subsequently
employed to form louisianin A (1) in 11 steps with an overall yield of 3.8%. To access
louisianin B required a reduction to form

the benzylic alcohol. This was done in two
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ways, either to form the racemic mixture or an enantiopure product. The racemic method
required a sodium borohydride reduction; Taylor was able to synthesize racemic
louisianin B (2) in 12 steps with an overall yield of 3.1%. The enantioselective synthesis
of (-)-louisianin B was completed through a Noyori reduction using a ruthenium catalyst.
The total synthesis of enantiopure (-)-louisianin B was completed in 12 steps in a 3.5%
overall yield.

TMSOK
DMAP, DCC,
CCI4 A, 24 h
56%

14

SPh

LHMDS,
P(OEt)3,
0 2, THF,
-15 °C, 3 h

SPh

SPh

AcOH/H20 (9:1),
135 °C, 72 h N

HN

75%

92%
i)m-CPBA,
CH2CI2, -15 °C
ii) Et3N, rt, 0.5 h
iii) C aC 03
xylene, 160 °C
71%
over 2 steps

86%

OH
SPh

SPh

SPh
1) 5 mol%-(S,S)-Noyori
Et3N/HC03H (5:2),
DMF, 40 °C, 24 h;
92% e.r. >99:<1
or
2) NaBH4, MeOH,
rt 1h
82% (+/-)

Louisianin A (1)

HN
OH

Louisianin B

Scheme 3.5 Taylor’s synthesis toward louisianin A and B
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(2)

Route Towards Louisianin B
Having optimized cycloreversion conditions on model substrates, we anticipated
an application toward the synthesis of louisianin B. We envisioned a late stage oxidation
to install the hydroxyl functionality on the fused cyclopentane ring system, followed by a
deprotection of the pyridone nitrogen to reveal the final natural product (Scheme 3.6). A
similar sequence as described in Chapter 2 would be used to convert the cycloadduct 17
into the desired pyridone. This cycloadduct would be constructed from the DMB DKP 18
and aliphatic aldehyde 19.

NH

Deprotection

NDMB

NDMB Cycloreversion

HO

Domino
S eq uence

O
Allylation and
Oxidation

NDMB
N
OMe

19

18

Scheme 3.6 Retrosynthesis of louisianin B route

Aldehyde 19 was simple in construction, first requiring an allylation of pent-4-ynl-ol using allyl bromide, potassium carbonate, tetrabutylammonium chloride, and copper
(I) chloride as a catalyst. Once the alkyne was allylated, it was oxidized using ParikhDoering conditions to reveal the final

aldehyde 19 with yield of 67% over two
68

steps. With the aliphatic aldehyde in hand, we attempted the one pot sequence with the
DMB protected DKP 18 (Scheme 3.7). Enolization of 18 with LiHMDS was followed by
addition of the aldehyde. Acetic anhydride was added to facilitate acetyl elimination upon
addition of DBU. Subsequent isomerization converted the elimination product into the
desired endo azadiene, setting up for an intramolecular Diels-Alder cycloaddition to
produce cycloadduct 17.
To access the desired louisianin pyridone, this cycloadduct was then submitted to
the conditions that were optimized in the methodological section. Potassium iodide and
acetic acid were used to deprotect the lactim ether bridge to form 20 , which could then be
functionalized with the electron-withdrawing acetate group. Microwave irradiation was
then able to afford the desired protected pyridone 21. After this, the only remaining step
besides deprotection was the oxidation of the benzylic position of the cyclopentane to
yield louisianin B.
i) LiHMDS, -7 8 °C
ii) O

O
r 1'

MeO.

NDMB

NDMB

OMe

iii) Ac20 , -7 8 °C to rt
iv) DBU rt to 90 °C
82%

AcOH,
100 °C

NDMB
-► HN

90%
17

20
Ac20

18

100 °C

O
[Ox]

NDMB

Microwave
72%
over 2 steps

Deprotection

Louisianin B (2)

O
^NDMB

21

Scheme 3.7 Synthetic scheme towards louisianin B with aliphatic aldehyde
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Since the desired oxidation position was benzylic with the most nucleophilic
character, we anticipated that the pyridone would most likely enolize at that position.
LiHMDS and LDA proved not to' form the enolate, resulting in starting material.
Knowing that enolization was the problematic step, we looked to use potassium tbutoxide as the base. Three equivalences of potassium /-butoxide caused oxidation at the
desired benzylic position; however, we also observed isomerization of the allyl group
resulting in 22 in 64% yield (Figure 3.2).

O

O
NH

HO

louisianin B

O
NDMB

NDMB
HO

22

23

Figure 3.2 Louisianin B and products from KOtBu oxidations

For this reason, we wanted to determine whether the isomerization or oxidation was
occurring first; to accomplish this, we performed the reaction at 0 °C with only one
equivalence of base. From this, we could determine that the isomerization was occurring
first, forming 23. Since the allyl group was inadvertently affected by the late stage
oxidation, we concluded that oxidation could not be performed after installation of the
allyl group without isomerization.
In 2006, Chang used potassium /-butoxide to isomerize an allyl group that had
been installed on a pyridine ring in their synthesis of louisianin D, although their work
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required the system to be heated to reflux in THF.5 Our experiment showed that even
though the isomerization required heat for Chang, we were able to isomerize and oxidize
our pyridone core at 0 °C.

Revised Route Towards Louisianin B
Because alkene isomerization during oxidation could not be prevented, we aimed
to synthesize an oxygenated aldehyde. It was unclear whether a substrate with a P-alkoxy
group would be compatible with the reaction conditions that had been optimized to form
2-pyridones. To form the desired azadiene 24 for the reaction sequence, DBU must
deprotonate Ha; however, deprotonation of Hb was possible, which could eliminate the (3alkoxy group to form elimination product 25 (Figure 3.3).

OR
Deprotonate
Ha
^
OR

T
Hb

Tf
N.

NDMB

O
OMe

DBU
R

R

O

I

NDMB

Hb

24
Deprotonate

OMe
—

O

R ^x^T ^N D M B
N" ' 'H a
OMe
25

Figure 3.3 Possible sites of deprotonation to form azadiene or elimination product

Even though it could not be predicted which position would deprotonate first, we
proposed a scheme in which the aldehyde would be constructed with a (3 functionality and
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carried through the domino sequence. This would set up for use of the optimized
cycloreversion conditions from Chapter Two and finally a deprotection of the pyridone
and benzylic alcohol to reveal louisianin B (Scheme 3.8).

NH

Deprotection

C>
V

NDMB Cycloreversion

* M eoM

ndmb

\ Z

^ =

■tr
OR

Domino
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OEt
I

Alkynylation,
Allylation and
Deprotection

q

||

EtO A ^ O E t

<

O

OR

H

NDMB
N.
OMe

Scheme 3.8 Retrosynthesis of revised route using oxidized aldehyde

We decided to form the alkyne functionality through addition into the carbonyl.
This step would install the alkyne as well as form the alcohol that is present in louisianin
B. Beginning with diethoxy propanoate, 26, we reduced the ethyl ester to aldehyde 27
(Scheme 3.9). This reduction set up for the Grignard addition of ethynylmagnesium
bromide into the aldehyde to form secondary alcohol 28. Because of the nonstereospecific manner of the Grignard reaction, two enantiomers were produced and
carried through the route. Initial attempts to attach an allyl group to the alkyne used the
same conditions as the initial route with allyl bromide, potassium carbonate,
tetrabutylammonium chloride, and the copper (I) chloride catalyst. It was noted that in
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one instance, the alcohol was allylated. For this reason, we first protected the alcohol
with TBS Cl to prevent undesired allylation. Once the alcohol 29 was protected, we could
use a stronger base, specifically w-BuLi, to deprotonate the alkyne, which could then act
as the nucleophile and undergo an Sn2 displacement with allyl bromide to form the
allylated product 30. The last step required deprotection of the acetal to reveal the final
oxygenated aldehyde 31.

OEt O

= — MgBr
THF, -78 °C
to rt

OEt OH
^

EtO

71%

27

OEt OTBS
EtO

i)n-Bul_i, THF, -78 °C,
ii)

30

28

TBSCI,
imidazole,
DMF, rt
97% /

CuCI, K2CO.
TBACI,
DMF, rt

OEt OTBS
EtO

Br

OEt OH
EtO

CuBr*SMe2, 50 °C
96%

+

OTBS

EtO

31

Scheme 3.9 Synthesis of oxidized aldehyde

The aldehyde is sensitive and must be used directly. Both stable aldehyde hydrate
32 and the product 33 arising from elimination of the (3-siloxy residue are observed
(Figure 3.4). Overall, the oxidized aldehyde could be synthesized in 5 steps with 30%
yield.
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32

33

Figure 3.4 Structure of hydrate and elimination products
With the oxygenated aldehyde, we were able to attempt a one-pot domino
sequence using the DMB DKP (Scheme 3.10). However, initial efforts with the one-pot
reaction resulted in a majority of DKP starting material. We proposed that the
problematic step in the reaction sequence was the aldol addition and have been currently
adjusting conditions to optimize the sequence. Two diastereomeric cycloadducts 34a and
34b were synthesized from the domino sequence, differing at the stereocenter containing
the TBS protected alcohol with a diastereomeric ratio of 3:2. This demonstrated that the
P-siloxy group did not have a significant impact on the diastereoselectivity of the
cycloaddition.
The lactim ether deprotection in acetic acid risked loss of the TBS group;
however, we did not observe this with our product. Once lactam 35 was formed, we
acetylated it and submitted the product to microwave irradiation without purification. Use
of the microwave for one hour and fifteen minutes resulted in the desired protected
pyridone 36.
The only remaining step required to access louisianin B was the removal of both
the DMB and TBS groups. We anticipated that we could cleave both protecting groups
simultaneously with the TFA conditions

that we had previously utilized to cleave
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the DMB group. After submission to the microwave for 10 minutes in 2:1 CFbC^TFA,
using temperature mode that would hold at 120 °C, we observed that complete conversion
was not achieved. We resubmitted the reaction mixture and held it at 120 °C for 30
minutes. It was observed that both the DMB group as well as the TBS group had been
cleaved. Comparing our ]H NMR spectrum to Taylor’s supported that we had
successfully constructed louisianin B. Overall, there were 10 steps in our synthesis with
an overall yield of 1.5% to access the desired pyridone.

i) LiHMDS, - 7 8 °C
jj) O
OTBS
NDMB

O

MeO
—

NDMB
N.

91%

iii) Ac20 , - 7 8 °C to rt
iv) DBU rt to 90 °C
29%

OMe
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34

Q
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OTBS

Ac20 ,
100 °C

'VNDMB

AcO

NDMB
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hn;

59%

35

OTBS

O

Kl,
AcOH,
1 0 0 °C

O

2:1 CH2CI2:TFA,
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NDMB
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32%

TBSO

OTBS

NH

HO

36
Louisianin B (2)

Scheme 3.10 Revised synthesis toward louisianin B with oxidized aldehyde

By

forming

an

oxygenated

aldehyde, we were able to construct the
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louisianin pyridone core efficiently, which revealed the final natural product after
removal of two protecting groups. Previously, only non-oxygenated aldehydes had been
utilized in our one-pot domino sequence, and it is interesting that the protected alcohol
was able to persist through the cycloreversion conditions. This example suggests that a
wider group of aldehydes could potentially be used to access pyridones with these types
of oxygenated substituents.

Conclusion
Overall, we were able to demonstrate the applicability of our methodological
work by applying it to the synthesis of louisianin B. We initially had attempted to use an
aliphatic aldehyde to achieve this goal, but a late stage oxidation proved to be
incompatible with the allyl substituent on the pyridone core. Eventually, we were able to
synthesize an aldehyde with a protected alcohol in the (3 position and use it in the domino
sequence to construct the desired [2.2.2]-diazabicyclic core. Furthermore, the protected
alcohol was able to withstand the conditions to form the 2-pyridone, showing a
potentially useful set of new aldehydes that could be explored with these conditions.
While conditions for this route have not yet been fully optimized, we have been able to
show that the final natural product can be formed through this sequence of conditions.
Overall, we have demonstrated the synthesis of louisianin B in 10 steps with a 1.5%
yield.
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E x p e r im e n ta l S e c tio n

o

oct-7-en-4-ynal (19). To oct-7-en-4-yn-l-ol (400 mg, 3.2 mmol) dissolved in
dichlormethane (10 mL) was added i-P^NEt (1.7 mL, 9.7 mmol) at 0 °C. A stock
solution of S 0 3 pyr (790 mg, 4.8), DMSO (7.5 mL) in dichloromethane (4.5 mL) was
prepared at 0 °C. Small increments of the stock solution were added to the reaction flask
until the reaction appeared to be complete as tracked by TLC. The reaction appeared to
be complete after about 1 hr. After cooling, the reaction was diluted with HC1 (10 mL)
and the organic layer was extracted with Et20 (3x10 mL). The combined organic layers
were diluted with NaHC03 (10 mL), washed with brine (10 mL), dried with NaS0 4 ,
filtered and concentrated in vacuo. The product was purified by flash chromatography on
silica gel (elution: 5% to 25% Et20 in pentane) to afford product oct-7-en-4-ynal (265
mg, 67% yield) as colorless liquid; TLC (40% EtOAc in hexane) Rf= 0.60 (KMn0 4 ); IR
(film) cm-1 3086, 3014, 2982, 2904, 2830, 2731, 1718, 1642, 1412, 1358, 1286, 1193,
1058, 993, 918, 850; !H NMR (400MHz, CDC13) 9.80 (s, 1H, CHO), 5.79 (m, 1H, C7H),
5.28 (ddd, J = 16.8/3.1/1.6 Hz, 1H), 5.10 (dt, J = 9.8/1.6 Hz, 1H), 2.93-2.91 (m, 2H),
2.68-2.66 (m, 2H), 2.54-2.50 (m, 2H) ; 13C NMR (100 MHz, CDC13) 5 200.6, 132.7,
115.6, 80.3, 77.6, 42.7, 22.8, 11.9 ; Exact mass calcd for C8Hi0ONa [M+Na]+, 267.1356,
Found 267.1354.
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o

o
NDMB

OMe

NDMB

'

(3£,7aS)-4-allyl-9-(2,4-dimethoxybenzyl)-2-methoxy-3,5,6,7-tetrahydro-3,7a(epiminomethano)cyclopenta[£>]pyridin-8-one (17): To diketopiperazine 18 (195 mg,
0.68 mmol) in toluene (7 mL) at -78 °C was added LiHMDS (1.0M in THF, 1.1 equiv.)
dropwise over 5 minutes by syringe. After stirring for 25 minutes at -78 °C, aldehyde 18
(125 mg, 1.2 equiv.) was added to the solution. AC2O (0.093 ml, 1.3 equiv.) was added
dropwise at -78 °C, and the solution was allowed to warm to room temperature while
stirring. DBU (0.203 ml, 2 equiv.) was added and the mixture stirred at rt for 16 hours.
The reaction was washed with NH4CI (20 mL) and extracted with EtOAc (10 mL x 3).
The organic layer was washed with brine (10 mL), dried with Na 2SC>4, and then
concentrated in vacuo. The reaction mixture was concentrated and purified by flash
chromatography on silica gel (elution: 10% - 50% EtOAc in hexanes) to afford a pale
yellow oil (220 mg, 82% yield).

TLC (40% EtOAc in hexanes), R/i 0.25

(CAM); IR (film) cm-1; H NMR (400 MHz, CDC13); 6.94 (d, 1H, J = 7.8 Hz), 6.37 (s,
1H), 6.35 (d, 1H, J = 7.0 Hz), 5.52 (m, 1H), 4.94 (s, 2H, J = 10.2), 4.75 (d, 1H J= 1.6),
4.37 (s, 1H), 4.30 (m, 2H), 3.73(s, 3H), 3.72 (s, 3H), 3.60 (s, 3H), 2.88 (m, 1H), 2.68 (dd,
1H, J — 15.6/6.3), 2.52 (dd, 1H, J = 15.6/6.6 Hz), 2.25 (m, 1H). 2.14 (m, 1H), 2.06-1.96
(m, 2H), 1.70 (m, 1H); 13CNMR(100 MHz, CDC13) 5 175.3, 171.8, 160.6, 158.4, 151.8,
133.9, 131.0, 130.6, 116.9, 116.6, 104.0, 98.1, 79.7, 61.1, 55.2, 55.0, 54.9, 42.8, 34.2,
30.0, 26.2, 26.1; HRMS (ES+): Exact mass calcd for C22H26N204Na [M+Na]+ 405.1784
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Found 405.1784.

NDMB

NDMB
^

HN

(3*S,7aS)-4-allyl-9-(2,4-dimethoxybenzyl)-3,5,6,7-tetrahydro-3,7a(epiminomethano)cyclopenta|7>] pyridine-2,8(1//)-dione (20): To product 17 (150 mg,
0.39 mmol) in AcOH was added KI (3 equiv.) and stirred at 100 °C for 2.45 hr. The
reaction was diluted with water (20 mL) and Na2CC>3 (10%, 10 mL) and extracted with
EtOAc ( 3 x 1 0 mL). The organic layer was washed with NaHC03 with thiosulfate (10
mL), brine (10 mL), dried with Na2S0 4 , and concentrated in vacuo to afford a tan powder
(130 mg, 90% yield). TLC (60% EtOAc in hexane), Rf. 0.35 (KMn04); IR(film) cm-1
2960,2838, 1696, 1663,1456, 1418, 1294, 1210, 1158, 1039, 922, 826; *H NMR
(400MHz, CDC13) 7.75 (br. s, 1H), 7.05 (d, J= 8.6 Hz, 1H), 6.43-6.38 (m, 2H), 5.53 (m,
1H), 4.99 (d, .7=10.2 Hz, 1H), 4.93 (dd, J= 16.8/1.6Hz, 1H), 4.54 (d, J = 14.5 Hz, 1H),
4.38 (d, 14.5 Hz, 1H), 4.20 (d, J = 1.6 Hz, 1H), 3.79 (s, 3H), 3.76 (s, 3H), 2.74 (m, 2H),
2.59 (dd, J = 15.2/5.9 Hz, 1H), 2.33-2.30 (m, 2H), 2.06-1.88 (m, 1H), 1.86-1.78 (m,
1H), 1.77-1.67 (m, 1H); 13C NMR (100 MHz, CDC13) 173.9, 170.3, 160.8, 158.6, 149.4,
133.7, 133.3, 131.3, 117.3, 116.6, 104.1, 98.3, 70.2, 65.8, 55.3, 55.1, 43.3, 34.7, 27.7,
26.4, 26.3; HRMS (ES+): Exact mass calcd for C21H24N 2O4 [M+Na]+, 391.1628.
Found 391.1624.
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'VNDMB

NDMB

4-allyl-2-(2,4-dimethoxybenzyl)-2,5,6,7-tetrahydro-l//-cyclopenta[c]pyridiii-l-one
(21): The lactam cycloadduct 20 (32 mg, 0.087) in AC2O (0.2 mL) and pyridine (0.2 mL)
was heated in a sealed tube to 100 °C for 19.5 hr and cooled to rt. The mixture was
concentrated in vacuo. The intermediate product was dissolved in toluene (2 mL) and
heated in a microwave system on power mode (300 W maximum) for 1.5 hr. The reaction
was concentrated in vacuo to afford a tan solid (25.8 mg, 91% yield). TLC (60% EtOAc
in hexane), Rfi 0.25 (CAM); IR (film) cm-1 2956, 2849, 1696, 1646, 1561, 1457, 1290,
1267, 1210, 1158, 1032, 920, 836; *H NMR (400MHz, CDC13) 7.35 (d, .7=9.0 Hz, 1H),
7.12 (s, 1H), 6.45-6.42 (m, 2H), 5.83 (m, 1H), 5.15 (m, 3H), 3.82 (s, 3H), 3.78 (s, 3H),
3.08-3.06 (d, J = 6.3 Hz, 2H), 2.87-2.82 (t, J =7.42 Hz, 2H), 2.77-2.74 (t, J= 7.4 Hz,
2H), 1.87 (m, 3H); 13CNMR(100 MHz, CDC13) 160.6, 158.4, 154.6, 135.8, 134.6, 131.9,
117.5, 116.3, 114.8, 104.1, 98.3, 55.3, 55.2, 46.6, 34.2, 32.4, 30.3, 23.2; HRMS (ES+):
Exact mass calcd for C20H23NO3 [M+Na]+, 348.1570 Found 348.1566.

5,5-diethoxypent-l-yn-3-ol (28): To 3,3-diethoxypropanal (1.1 g, 8.22 mmol) in THF
(70 mL) at -78 °C was added ethynyl magnesium bromide (22.5 mL, 0.5 M, 12.4 mmol)
81

dropwise. The reaction vessel was slowly warmed to room temperature and then stirred
overnight. The reaction was washed with NH4CI (50 mL) and extracted with EtOAc (3 x
25 mL). The organic layer was washed with brine (30 mL), dried with Na2S0 4 , and then
concentrated in vacuo. The reaction mixture was purified by flash chromatography on
silica gel (elution: 5%-50% EtOAc in hexanes) to afford a yellow oil (925 mg, 71%
yield). TLC (40% EtOAc in hexanes), Rf: 0.40 (KMn04); IR (film) cm-1 3419, 3294,
2973, 2892, 2118, 1445, 1375, 1349, 1215, 1130, 1057, 848, 806; H NMR (400 MHz,
CDCI3) 4.77 (t, J = 5.67 Hz, 1H), 4.46 (m, 1H), 3.68-3.53 (m, 2H), 3.52-3.41 (m, 2H),

2.41 (d, J= 1.95 Hz, 1H), 1.96 (t, J= 5.67 Hz, 2H), 1.18-1.05 (m, 6 H); 13C NMR (100
MHz, CDCI3) 6 101.0, 84.1, 72.7, 62.3, 61.8, 58.9, 40.2, 15.2, 15.2; HRMS (ES+): Exact
mass calcd for [M+Na]+, 195.0992. Found 195.0993.

OEt OH

OEt OTBS

terr-butyl((5,5-diethoxypent-l-yn-3-yl)oxy)dimethylsilane (29): To 28 (200 mg, 1.16
mmol) in DMF (0.6 mL) was added imidazole (166 mg, 2.44 mmol) stirred at rt for 30
min. Tert-butyl chlorodimethylsilane (192.9 mg, 1.28 mmol) was added at rt and the
reaction was allowed to stir overnight. The reaction was diluted with water (mL),
extracted with EtOAc (3 x mL). The organic layer was washed with brine (mL), dried
with Na2S0 4 , and concentrated in vacuo to afford a yellow oil (322 mg, 97% yield). TLC
(40% EtOAc in hexane), Rf. 0.70 (KMn04); IR (film) cm-1 3312, 2978, 2934, 2858,
2110. 1718, 1636, 1617,1374, 1275, 1123, 1093, 1062, 935, 840;‘H NMR (400MHz,
82

CDC13) 4.58 (dd, J= 4.86/1.95 Hz, 1H), 4.21 (m, 1H), 3.64-3.33 (m, 2H), 2.32 (d, J =
2.35 Hz, 1H), 1.98-1.85 (m, 2H), 1.14-1.10 (td, J = 7.03/2.34 Hz, 6 H), 0.82 (s, 9H),
0.06-0.03 (d, J= 14.8 Hz, 6 H); 13C NMR (100 MHz, CDC13) 99.9, 85.1, 72.4, 61.7, 61.2,
59.5, 42.6, 25.7, 18.1, 15.3, 15.25, -4.6, -5.3; HRMS (ES+): Exact mass calcd for
[M+Na]+, 309.1856. Found 309.1858.

OEt OTBS

OEt OTBS

EtO

ter/-butyl((l,l-diethoxyoct-7-en-4-yn-3-yl)oxy)diinethylsilaiie (30): To 29 (250 mg,
0.87 mmol) in THF (0.6 mL) at -78 °C was added n-BuLi (2.84M, mmol) dropwise. The
reaction was stirred for 30 min at -78 °C. To the solution was added allyl bromide (92 pi,
1.07 mmol) and copper (I) bromide dimethyl sulfide (9.2 mg, 0.045 mmol) and the
reaction was heated to 50 °C overnight. The mixture was washed with NH4CI (10 mL),
extracted with EtOAc ( 3 x 1 0 mL). The organic layer was washed with brine (10 mL),
dried with Na2S04 and concentrated in vacuo to afford a yellow oil (268 mg, 94% yield).
TLC (40% EtOAc in hexane), Rfi 0.80 (KMn04); IR (film) cm-1 2978, 2935, 2860, 1643,
1373, 1351, 1253, 1123, 19087, 1074, 985, 915, 834, 778; lU NMR (400MHz, CDC13)
5.77 (m, 1H), 5.28 (d, J= 17.2 Hz, 1H), 5.08 (dd, J= 9.96 Hz, 1H), 4.65 (t, J= 5.28 Hz,
1H), 4.48 (m, 1H), 3.56 (m, 4H), 2.96-2.94 (m, 2H), 1.97 (m, 2H), 0.884-0.881 (d, J =
1.77 Hz, 9H), 0.79-0.09 (d, J= 11.9/0.78 Hz, 6 H); 13C NMR (100 MHz, CDC13) 132.3,
115.9, 100.0, 83.8, 81.0, 61.5, 60.928, 59.9, 42.9, 25.7, 25.6, 22.9, 18.0, 15.3, 15.2, -4.5,
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-5.2; HRMS

(ES+):

Exact

mass

calcd

for

C20H23NO 3 [M+Na]+,

349.2169.

Found 349.2169.

OEt OTBS

O

OTBS

3-((te/T-butyldimethylsilyl)oxy)oct-7-en-4-ynal (31): To 30 (225 mg, 0.69 mmol)
dimethylsilane dissolved in CHCl3(6 mL) was chilled to 0 °C. A 1:1 mixture of TFA in
FLO (6 mL) was added dropwise. The reaction was allowed to stir at 0 °C for 2.5 h and
warmed to room temp and allowed to stir for 3 h. The reaction was quenched with
NaHCOs (10 mL), extracted with CHCI3 ( 3x10 mL). The organic layer was washed with
brine (10 mL), dried with Na2S04 and concentrate in vacuo to afford a pale yellow oil
(102 mg, 59% yield). TLC (40% EtOAc in hexane), R/: 0.85 (KMnOzO; IR(film) cm-1
2959, 2934, 2887, 2856, 2740, 2711, 2234, 1732, 1696, 1636, 1561, 1458, 1339, 1282,
1143, 988, 914, 835, 781; *H NMR (400MHz, CDC 13) 9.71 (s, 1H), 5.66 (m, 1H), 5.16
(dq, 1H, J = 17.2/1.7 Hz), 5.00 (dq, 1H, J = 10.2/1.6 Hz), 4.76 (m, 1H) 2.87-2.84 (m,
2H) 2.66-2.51 (qdd, J = 17.3/6.2/2.8 Hz, 2H), 0.88 (s, 9H), 0.15 (s, 3H), 0.12 (s, 3H); 13C
NMR (100 MHz, CDCI3) 200.8, 132.0, 116.2, 82.8, 82.4, 58.5, 51.6, 25.6, 22.0, 18.0, 4.5, -5.2; HRMS (ES+): Exact mass calcd for CwHwOiSi [M+Na]+, 275.1438.
Found 275.1440.
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o
NDMB

M e O -J

N;
OMe

OTBS

(35',7aS)-4-allyl-5-((fc^-butyldimethylsilyl)oxy)-9-(2,4-dimethoxybenzyl)-2-methoxy3,5,6,7-tetrahydro-3,7a-(epimmomethano)cyclopenta[£]pyridin-8-one (34a and 34b):
Prepared according to general procedure A using DKP 17 (50 mg, 0.18 mmol) and
aldehyde 31. The product was purified by flash chromatography on silica gel (elution:) to
afford two diastereomers as clear oils (34a: 15 mg, 0.029 mmol, 16% yield) (34b: 12 mg,
0.023 mmol, 13% yield): 33a: TLC (40% EtOAc in hexane), R/i 0.55 (UV, CAM); ]H
NMR (400 MHz, CDC13) 7.00 (d, J= 7A Hz, 1H), 6.44-6.40 (m, 2H), 5.56 (m, 1H), 5.04
(d, J= 9.8 Hz, 1H), 4.93 (dd, J = 17.2/1.6 Hz, 1H), 4.73 (t, J = 5.67 Hz, 1H), 4.45 (s,
1H), 4.36 (s, 1H), 3.81 (s, 3H). 3.79 (s, 3H), 3.68 (s, 3H), 2.94 (dd, J = 15.6/5.9, 1H),
2.80-2.66 (m, 2H), 2.37 (m, 1H), 2.10-1.93 (m, 2H), 1.67 (s, 9H), 0.07 (s, 3H), 0.03 (s,
3H); 13C NMR (100 MHz, CDC13) 5 176.0, 172.2, 160.8, 158.5, 152.0, 134.7, 134.1,
131.3, 117.3, 117.1, 104.8, 104.1, 98.4, 78.0, 70.6, 61.8, 55.4, 55.3, 55.2, 43.0, 36.3, 33.0,
26.4, 25.8, 25.7, 18.0, -4.4 -4.9; 33b: TLC (40% EtOAc in hexane), R/i 0.65 (UV, CAM).

NDMB

NDMB
HN

OTBS

OTBS

To product a mixture of 34a and 34b (36 mg, 0.071 mmol) in AcOH was added KI (3
equiv.) and stirred at 100 °C for 1.5 hr. The

reaction was diluted with water (15 mL)
85

and Na2CC>3 (10%, 10 mL) and extracted with EtOAc (3x10 mL). The organic layer was
washed with NaHC03 with thiosulfate (10 mL), brine (10 mL), dried with Na2S0 4 , and
concentrated in vacuo to afford a tan powder (32 mg, 91% yield).

O
NDMB

NDMB

4-allyl-5-((/er/-butyldimethylsilyl)oxy)-2-(2,4-dimethoxybenzyl)-2,5,6,7-tetrahydrol//-cyclopenta[c]pyridin-l-one (35): Following general procedure C, using lactam 34
(32 mg, 0.064 mmol) the intermediate acylated product was produced (34 mg, 0.063
mmol, 98% yield). This intermediate product was used to produce the desired acetylated
product following general procedure D. The product was purified by flash column
chromatography on silica gel (elution:) to afford the product 36 (17 mg, 0.037 mmol,
59% yield) as a yellow oi l : TLC (5% MeOH in chloroform), R/i 0.6 (UV, CAM).
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